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ABSTRACT

Studies of fluorescent imaging for mRNA
detection in living cells
By
Zhenghui Wang

Doctor of Philosophy in Chemistry
Washington University in St Louis, 2011
Professor John-Stephen Taylor, Chairperson

This dissertation focuses on the study of imaging mRNA in living cells. To
achieve this research objective, three approaches have been utilized: (1) Imaging of a
transgenic mRNA tagged by multiple repeats of malachite green (MG) binding aptamer.
(2) Imaging of inducible nitric oxide synthase (iNOS) mRNA by strand-displacement
activated Peptide Nucleic Acid (PNA) probes. (3) Imaging of iNOS mRNA by binary
fluorescently labeled PNA probes.
The first approach was based on the work of our former lab member Dr. Huafeng
Fang, who had constructed a multiple MG binding aptamer tagged transgene (Flagmβ2AR-GFP-MGVI), which could also express a green fluorescence protein associated
with an adrenergic receptor protein. It has been reported that the tagged aptamer sequence
can increase the fluorescence of MG up to 2000 fold by binding to MG. Total RNA
extract of the transfected MDCK cells has shown up to 22 times increase of fluorescence
in the presence of MG. Confocal fluorescence imaging study has shown that in the
ii

presence of MG, cells expressing the transgene showed both the fluorescence of GFP and
enhanced fluorescence of MG. A flow cytometry study detected that in the presence of
MG and transfected cells showed 1.3 fold increase of fluorescence compared to the wild
type MDCK cells.
The next approach was to use strand-displacement activated PNA probes to detect
the iNOS mRNA in living RAW 264.7 mouse macrophage cells. A probe constitutes of
an antisense 23-mer fluorescein (FAM) labeled antisense PNA and a 17-mer Dabcylplus
labeled complementary DNA was used. The fluorescence of the FAM was quenched
when the two strands hybridized to each other. In the presence of target mRNA, the
shorter strand was displaced by the mRNA, which has more base pairs complementary to
the PNA. The fluorescence of FAM was restored and thus could be used to detect the
mRNA. The probe has been shown to be able to detect the target DNA and in vitro
transcribed mRNA in solution. Fluorescence in situ hybridization (FISH) showed that the
probes showed 3.6 (± 1.8)-fold increase of fluorescence between stimulated cells
expressing a high level of iNOS mRNA and non-stimulated cells. Cationic Shellcrosslinked Knedel-like (cSCK) nanoparticles were employed to deliver probes into
living cells and the fluorescence of the stimulated cells observed by confocal microscopy
increased 16.6 (± 7.9)-fold. RT-PCR was conducted to determine the absolute copy
number of the iNOS mRNA in cells. The detected increase of iNOS mRNA after 18
hours of stimulation was around 100 times, and the actual copy number of the mRNA per
cell was around 70000. These results reveal that the under our current systems, stranddisplacement probes are not sufficient to report quantitatively on the mRNA copy
numbers in living cells, but they can be used to achieve mRNA imaging in living cells.
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The third approach was to use fluorescent labeled binary PNA probes to image
the iNOS mRNA in living RAW 264.7 cells. PNAs bearing FAM and Cy5 and targeting
the adjacent sites of the iNOS mRNA were synthesized and had shown FRET signal upon
binding to the DNA target and in vitro transcribed iNOS mRNA in solution. The probes
were delivered into living cells by hybridizing to their partially complementary DNAs
and forming complexes with cSCK nanoparticles. Fluorescent images were taken by
confocal microscope. The matched probes showed FRET image for stimulated cells
while control probes showed almost no FRET signal and non-stimulated cells treated
with matched probes showed weak signal. The average FRET intensity detected in
stimulated cells was 3.8 (± 0.9) times higher than in non-stimulated cells.
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Chapter One
Introduction
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1.1 Gene expression, antisense inhibition and mRNA imaging
Messenger RNA (mRNA) is a macro-molecule that is involved in gene expression
and protein production in almost all species. In eukaryotic cells, mRNA is produced in
the nucleus from pre-mRNA which is transcribed from the DNA template with the help
of RNA polymerase and several other enzymes. The pre-mRNA transcribed from DNA is
then processed by spliceosomes to form the mature mRNA. The DNA coding for the
spliced parts are called introns and the intervening parts are referred to as exons. The
mature mRNA is then transported to the ribosome in the cytoplasm, where it is translated
into protein through the use of aminoacyl transfer RNAs (aa-tRNAs) which align with the
mRNA via base pairing between 3-nucleotide segments known as codons. Each aa-tRNA
carries a specific amino acid. These amino acids are covalently joined by the ribosome to
form a polypeptide. In this way, the sequences of the nucleotides in DNAs specify the
sequences of the amino acids in the proteins (Figure 1.1).
The important role of mRNA in gene expression has led to the development of a
variety of methods for its detection and regulation. For example, researchers use
antisense nucleic acids to bind and manipulate mRNAs produced by certain genes [1, 2].
These nucleic acids probes are complementary to mRNA sequences, which are known as
“sense” sequences. By hybridizing to the mRNA, the nucleic acid probes can either block
the translation of the mRNA or cause enzymatic degradation of the mRNA. The clinical
application of these antisense oligonucleotides is termed antisense gene therapy [3].
Researchers have developed various nucleic acid analogs for antisense inhibition,
including phosphorothioate DNA [4], 2’-O-methylated RNA [5], peptide nucleic acid
(PNA) [6-9], locked DNA (LNA) [10, 11], and other analogs [12] (Figure 1.2). Recently,
2

it has been discovered that some short double strand RNAs called “small interfering RNA”
(siRNA) can also silence gene expression [13, 14]. These types of RNAs, which are
usually 20 to 25 nucleotides in length, can cause the degradation of the targeted mRNA
through “RNA interference pathway” that involves the RNA-induced silencing complex
(RISC).

Figure 1.1: A schematic representation for gene expression
(Remixed from Wikipedia under GNU Free Document License)
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Figure 1.2: Some typical DNA analogs
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Besides the antisense inhibition and silencing of mRNA, it is also of interest to be
able to measure and image mRNA transcripts. For example, in some diseases or cancers,
certain genes may be over-expressed and it would be useful to be able to detect and
control the abnormal gene expression [15, 16]. There are many ways to monitor gene
expression. For example, researchers can monitor gene expression at protein level via
immunohistochemical staining [17], western blot [18], mass spectrometry [19] and other
techniques. However, a more direct way to monitor gene expression would be to detect
the mRNA. Many techniques have been developed to quantify gene expression at the
mRNA level, such as: Northern hybridization (Northern blot) [20], real-time polymerase
chain reaction (RT-PCR) [21-23], DNA microarray [16, 24], etc. These techniques have
all been proved to be powerful tools to quantitatively measure the change in mRNA
expression. Some techniques, for example RT-PCR, can even detect a few copies of
mRNA per cell [25]. These methods, however, also have drawbacks. Most of them are
time consuming and destructive, requiring lysis of cells or tissue samples. It would be
advantageous to have methods that can detect, as well as image, mRNA inside living
cells and in vivo.
Many techniques have been developed for mRNA imaging and quantification, most
of which rely on the detection of optical or radioactive signals. One way to monitor the
expression of RNA is to tag a transgene mRNA with aptamers that can increase the signal
intensity of a fluorescent probe [26, 27], a strategy that will be discussed in more detail in
chapter two. In another approach, a transgene mRNA is tagged with a protein binding
sequence, such as the MS2 protein binding sequence, which is then recognized by the
protein fused to a fluorescent protein [27]. Another approach is the spliceosome-mediated
5

RNA transplicing (SMarRT), in which an RNA transcript of a reporter protein (such as a
luciferase) is engineered to ligate with a target pre-mRNA during trans-splicing process.
The trans-spliced mRNA expression can then be monitored by detecting the signals from
the co-expressed reporter protein [28].
Besides the transgenic methods, another general approach is to image endogenous
mRNA using antisense nucleic acid probes. These probes achieve their specificity via
Watson-Crick base pairing, in which adenine (A) forms a base pair with thymine (T)
and guanine (G) pairs with cytosine (C), via hydrogen bonding [29]. The antisense probes
are then conjugated to reporter groups and are 20 to 50 nucleotides in length so as to
achieve specificity for targeting DNA or RNA. Some of the most commonly used
reporter groups are radioactively labeled molecules, which can be detected by radiation
sensitive detectors [30-32]. Another type of reporting group are fluorescent molecules
[33-36]. Researchers have also developed fluorescent quantum dots that can be
conjugated to nucleic acid probes. These quantum dots, usually nanocrystals made from
inorganic materials, have higher extinction coefficients and similar quantum yields to the
commonly used organic fluorescent molecules. They are usually brighter and have
narrower emission lines, making them more suitable for biological imaging [37, 38]. The
use of nucleic acid probes to detect and image mRNA will be the main topic of this thesis
and will be discussed extensively in the following sections.

1.2 Molecular imaging using nucleic acid probes
Because of the simplicity of targeting mRNA (or DNA) by Watson-Crick base
pairing, nucleic acid probes have been widely used for mRNA imaging. The two basic
6

types of probes are: always-on probes and light-up probes. Details of each of these types
of probes will be discussed in the following sections (Figure 1.3).

1.2.1 “Always-on” probes
“Always-on” probes are the simplest type of nucleic acid probes. There are
usually 25-30 nucleotides for a probe constructed by DNA and around 50 nucleotides for
a probe constructed by RNA [36]. To achieve specificity, the probes have to be of certain
length, because the shorter the probe, the greater possibility that it will bind to non-target
mRNAs that share the same sequences as the target. Also, if the sequence is too short, the
melting temperature will be too low for a probe to bind effectively to its target under
physiological conditions [39]. The un-paired bases (or mismatch bases) will destabilize
the binding, therefore, only the perfectly matched sequences will have the highest binding
affinity to the target [40-42]. However, these probes are difficult to enter or exit cells
even with modifications. Often delivery involves endocytosis which results in high
background signals because most of the probes remain trapped in endosomes. Even if the
probes enter the cytoplasm, unbound probes may not be able to exit the cell efficiently,
and they can bind non-specifically to proteins and other mRNA/DNAs inside the
cytoplasm [30]. Furthermore, DNA and RNA probes are also prone to enzymatic
degradation inside cells. Therefore, these probes are often used with cell lysates or in situ
hybridization, where intracellular delivery of the probes is not a problem.
One of the most widely used techniques for quantifying mRNA involving always-on
probes is fluorescence in situ hybridization (FISH) [43-45]. Cells or tissues are treated
with fixatives (such as formaldehyde or methanol) to fix the cellular morphology and
7

allow the probes to penetrate the cell. To reduce the background signal generated by the
non-specific binding, stringent washing steps are used. Sometimes an amplification step
is used to achieve better signal to noise ratio, in which the probe is conjugated to a
molecule that can bind carriers with multi signaling molecules, such as antibodies,
biotin/avidin conjugated fluorophores [46], or horseradish peroxidase to catalyze
oxidation of tyramide [47, 48].

1.2.2 FRET-based “light-up” probes
To avoid the drawbacks of the always-on probes, researchers have developed probes
that only “light-up” upon binding to the target. Examples of these probes include: nucleic
acid templated profluorescent probes [49], hybridization triggered fluorogenic probes
[50-53], molecular beacon probes [54, 55], strand-displacement probes [56], and binary
FRET probes [57, 58], etc. One type of the “light-up” probe that will be investigated
extensively in this thesis is the FRET probe, which utilizes a Förster resonance energy
transfer (FRET) mechanism to transfer energy from one probe to another through space
[58]. This is a nonradiative dipole-dipole coupling process in which energy from an
energetically excited molecule is transferred to another molecule in close proximity. As a
result, the energy level of the first molecule, known as the “donor”, returns to the ground
state, rendering the decrease of the fluorescence intensity and lifetime. The second
molecule, known as the “acceptor”, could either emit fluorescence at longer wavelength
than the donor (red-shifted emission), or release the energy without emitting fluorescence
(fluorescence quenching) [59-61].
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The efficiency of the FRET depends on three main factors: the distance between the
donor and the acceptor, the overlapping between the donor’s emission spectrum and the
acceptor’s absorption spectrum, and the relative orientation of the donor’s emission
dipole and the acceptor’s absorption dipole moment. The FRET efficiency is the quantum
yield of the energy transfer transition, and depends on a number of parameters as shown
in the following equation:
𝐸 = 𝑘𝑒𝑡 /(𝑘𝑓 + 𝑘𝑒𝑡 + � 𝑘𝑖 )

where k et is the rate of energy transfer, k f is the relative decay rate, and k i are constants
for any other de-excitation pathways. The efficiency E also depends on the distance
between the two molecules and is described as [62, 63]:
𝑅 6
𝐸 = 1/(1 + � � )
R0

where R 0 is the Förster radius for a given pair of donor and acceptor molecules and R is
the actual distance between the two molecules. For a given FRET pair, R 0 depends on the
overlap integral of the donor emission spectrum with the acceptor absorption spectrum
and their mutual molecular orientation, which are described by the following equation:
R60 = 8.8 × 10−28 ∙ Φ(D) ∙ 𝜅 2 ∙ 𝜂 −4 ∙ J(λ)

where J(λ) is the spectral overlap of donor emission and acceptor excitation, 𝜂 the index

of refraction, Φ(D) the fluorescence quantum yield of the donor and 𝜅 the orientation
factor of the donor and acceptor dipole moments.

A typical effective distance for FRET is 1-10 nm, which roughly corresponds to a
distance of 3 to 30 nucleotides along the double helix of a DNA molecule. When the
9

distance between two dyes is close enough, fluorescent quenching can also occur by the
formation of a nonfluorescent complex, which is also known as “contact quenching” or
“static quenching” [64]. In this quenching phenomenon, the absorption spectra of the two
molecules will change when they form a complex, whereas in FRET, the absorption of
the two molecules will not change [65]. The following contents will discuss some typical
designs of the probes that employ FRET.

1.2.2.1 Binary FRET probes
Binary probes consist of two single-strand molecules, one conjugated to a “donor”
and the other to an “acceptor”. [57, 63, 66, 67]. When unbound to a target, the two singlestrands will not interact with each other, and the emission of the acceptor won’t be
observed upon the excitation of the donor. Upon binding to a target mRNA, which serves
as a molecular template, the two fluorophores are held close to each other so that an
effective FRET can occur. The most common way to monitor a FRET signal is via two
color ratio imaging (also known as sensitized emission), where the donor is excited and
the emission of both donor and acceptor is collected [68].

10

Figure 1.3: Typical designs of optical nucleic acid probes
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This FRET system is a great improvement to the single “always-on” probes in that
the fluorescence of the donor in the unbound state will cause little interference with the
FRET signal arising from the acceptor in the bound donor acceptor pair. Researchers
have used this type of FRET probe to detect mRNA both in vitro and in living cells [35,
69]. Sometimes however, the laser that excites the donor will also excite the acceptor, or
the fluorescence of the donor may overlap with emission from the acceptor [70],
rendering a false positive signal. Therefore, a typical FRET experiment requires a number
of controls to eliminate false-positive signals.
There are ways to minimize signals emanating from unbound probes. One way is to
measure the fluorescence life time of the donor using a technique called fluorescence
lifetime imaging microscopy (FLIM) [68]. Most fluorescent molecules used for FRET
exhibit a decay in fluorescence with half life on the nanoseconds scale. The fluorescence
lifetime of the donor is sensitive to the outside environment, and will decrease in the
presence of an acceptor in FRET. FLIM only measures the fluorescence life time change
of the donor, which is indicative of FRET, and will have fewer artifacts compared to
measuring the fluorescence intensity of the acceptor [71]. One drawback of this method is
that it requires sophisticated instrumentation that can measure fluorescence life time at
the nano second time scale. It is also a slower imaging technique, taking a few minutes to
obtain each image. Other environmental effects can also alter the fluorescence life time of
the donor; so that careful processing is required for live cell imaging.
Another approach to detecting FRET is the acceptor photo bleaching FRET [68, 72].
This method monitors the restoration of fluorescence of the donor after removal of the
FRET acceptor by photo bleaching. FRET can also be detected by polarization anisotropy
12

imaging. When excited by a linearly polarized laser, the fluorescence anisotropy of the
molecule can be determined from intensity measurements parallel and perpendicular to
the incident polarization. When there is FRET between two molecules, the fluorescence
of the donor will be depolarized, and such depolarization can be recorded to monitor the
FRET between two molecules. This technique is usually applied to fluorescent protein
imaging [68].
Besides two-probe FRET, there is a variation called “tandem FRET” where the
FRET occurs between three or more fluorophores [57, 73], with the first one’s emission
overlapping with the second one’s absorption and the second one’s emission overlapping
the absorption of the third, etc. This design further reduces interference from the emission
of the donor, but requires more stringent conditions and has lower overall FRET
efficiency.

1.2.2.2 Quenched autoligation FRET probes (QUAL-FRET probes)
A different approach to improving FRET probes involves mRNA templated
covalent ligation of a pair of FRET probes in which the ligation reaction activates an
otherwise quenched donor probe. In this design, one probe contains a donor fluorophore
and a quencher, while the second probe contains an acceptor fluorophore and a
nucleophilic group. When simultaneously bound to the target mRNA, the quencher of the
donor probe is displaced by the nucleophile that is conjugated to the acceptor probe. The
donor, is now no longer quenched, and can transfer its energy to the acceptor dye via
FRET. This design further reduced the background signal from the free donor probes.
Eric Kool et al. have developed such quenched autoligation or QUAL-FRET probes to
13

detect rRNA in bacteria and image mRNA in living cells. The ligated probe can
dissociate from the template, triggering another round of probe binding and ligating, and
the FRET signal can be amplified [74, 75],

1.2.2.3 Molecular beacons (hairpin probes)
Another type of widely used probes is a molecular beacon [76-78]. The molecular
beacon is a single-strand probe that forms a “stem and loop” structure, which is also
known as a “hairpin”. The stem usually comprises 5-7 pairs of complementary
nucleotides, with a fluorophore on one end and a quencher on the other. The loop is the
recognition part of the probe, and is complementary to the target mRNA sequence. In the
absence of the target sequence, the two strands of the stem hybridize together, bringing
the two moieties in close proximity so that the fluorescence of the “donor” molecule is
quenched by the quencher [64]. In the presence of the target, the hairpin will open and
the loop (and maybe part of the stem) will hybridize to the target DNA or mRNA. The
conformational change of the beacon will separate the donor and the quencher and the
fluorescence of the donor will be restored upon excitation. This is also a “switched-on”
probe that will theoretically reduce the background signal when the probe is in its
unbound state. A variation of this probe is to conjugate the same fluorophore to both ends
of the beacon. Some fluorescent molecules, such as pyrene, whose fluorescent properties
depend on proximity, can form “excimers”, which will have different fluorescent
properties than the monomer [79, 80].
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1.2.2.4 Dual beacon FRET probes
Dual beacon “FRET” probes are the combination of the molecular beacon and
binary FRET probes. In this design, two FRET probes are made into molecular beacons,
and thus the fluorescence of both the donor and the acceptor is quenched in the unbound
state. Upon hybridization to a target mRNA, the two beacons open up, and the donor and
the acceptor are no longer quenched so that FRET can occur. This design eliminates the
background signal of the donor and acceptor in their unbound states. Gang Bao and
coworkers have shown that such dual FRET probes can be utilized to image mRNA both
in vitro and in living cells [81, 82].

1.2.2.5 Strand-displacement probes
Strand-displacement probes are double strand probes with a fluorophore attached
to one strand and a quencher attached to a complementary strand [56, 83, 84] and are thus
similar to molecular beacons. The fluorescence of the fluorophore is quenched via FRET
or, if close enough, via contact quenching [64]. Upon binding to a target, one of the
strands will be displaced by the target to form a more stable duplex. The two original
strands are no longer hybridized to each other and the fluorescence on the reporter strand
will be restored. This is a “switched-on” type of probe, which means that it will only emit
fluorescence upon binding to the target. This solves the high background noise problem
caused by the “always-on” probe. This probe is also known as “Yin-Yang” probe [85],
which means “off-on” in Chinese philosophy. The two strands of the probe are usually of
different lengths, which will facilitate the displacement reaction and favor binding of the
target [56].
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1.3. Current obstacles in mRNA imaging and solutions
Despite the rapid development of agents for mRNA imaging using nucleic probes,
some problems still exist for using these probes for in vivo imaging [27]. The following
sections will discuss some obstacles to in vivo mRNA imaging using nucleic probes and
current approaches to surmounting them.

1.3.1 In vivo stability of the probes
Probes made from DNA and RNA are labile to enzymatic degradation under
biological conditions. To overcome these drawbacks, researchers have developed a
variety of nucleic acid analogs, which, while retaining the recognition features of the
probes (Watson-Crick base pairing), have modifications on the backbones of the probes
so that they are more resistant to enzymatic activities. Some of the most commonly used
modified probes include 2’-O-methylribonucleotides [86, 87], locked DNA (LNA) [88,
89], and peptide nucleic acids (PNA) [90, 91]. Another advantage of these analogs over
DNA is that they will not trigger RNase H degradation of the mRNA target, as will DNA
[92]. While degradation of the target mRNA might be useful for blocking gene
expression, it is not desirable for mRNA imaging purpose. Some of the mimics, such as
PNAs and 2’-O-methylribonucleotides, are more resistant to nuclease activity [93], and
won’t trigger RNase H activity [94], so that the target mRNA will be preserved for
imaging purpose. In this thesis, we will focus extensively on using PNA probes for in
vitro and in vivo imaging.
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1.3.2 Cellular delivery of nucleic acid probes
Another problem with the use of nucleic acid probes in vivo is their membrane
impermeability. Because most of the nucleic acid probes are neutral or negatively
charged, and most of the mammalian cells membranes are also negatively charged, it is
difficult for the probes to associate with cell membranes. Nucleic acid probes are also too
large and polar to cross the hydrophobic portion of the membrane by diffusion. The
following contents will discuss several strategies developed to solve the delivery problem.

1.3.2.1 Delivery of nucleic acid probes by cell penetrating peptide (CPP)
One solution to enhance cell permeation is to attach a cell penetrating peptide
(CPP) to the probes [95-99]. CPPs are short peptides that facilitate the cellular uptake of
the cargo, such as molecular probes, proteins, or nano-particles. These peptides usually
contain many positively charged amino acids, such as lysine, or arginine, and are either
covalently [97], or non covalently [100] attached to the probes. The mechanisms by
which these CPPs enter cell membranes can be generally categorized into two pathways:
energy dependent endocytosis and energy-independent translocation across the lipid
bilayer [101]. A recent study on CPP penetrating mechanism has shown that for some
commonly used CPPs (TAT, arginine 9, and the antennapedia/penetrating peptide etc.),
multiple

pathways may be involved, such as macropinocytosis, clathrin mediated

endocytosis

and

caveolae/lipid

raft

mediated endocytosis

[102].

Although

a

comprehensive understanding of the CPP penetrating mechanism is still under study,
CPPs have been proved to enhance the delivery of cargo probes across the cell
membranes, for example, Gang Bao and coworkers have constructed a molecular beacon
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conjugated to TAT-1 peptide via both cleavable and uncleavable bonds and utilized such
peptide-linked beacon probes to image the GAPDH mRNA inside living cells [103].

1.3.2.2 Delivery of nucleic acid probes by lipids
Taking advantage of the fact that viruses can efficiently carry their genome and
invade host cells, researchers have achieved gene delivery via recombinant viral vectors
[104]. This has triggered the research on developing synthetic vectors to delivery cargos
(probes, proteins or drugs) into cells. One type of such delivery system is to use cationic
lipids [105, 106]. Because DNA probes are negatively charged, they can associate with
the cationic lipids via electrostatic interactions to form lipoplexes. These lipoplexes then
interact with cell membranes and the cargo is then released into the cytoplasm when the
liposomes fuse with anionic cell membranes [105]. For probes that are not negatively
charged, such as PNA probes, an alternative method is to hybridize the probes with
negatively charged DNA probes to form negatively charged heteroduplexes so that they
will interact with positively charged lipids [107]. These lipoplexes can achieve effective
delivery of the gene or antisense probes, however, their stability, cytotoxicity and ability
to form homogeneous liposomes still need to be improved [108].

1.3.2.3 Delivery of probes by nanoparticles
Another type of synthetic vector for probe delivery are cationic polymers
(nanoparticles). These polymers, usually containing protonated primary, secondary or
tertiary amines, are positively charged and interact with the negatively charged DNA or
siRNA to form polyplexes [109, 110]. These polyplexes can also protect the nucleic acid
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cargo from degradation by various enzymes in the cellular environment [111]. Some
particles have tunable pH adjustability, which facilitate the endosomal escape of the
delivered cargo [112]. Typical examples of the nanoparticles used for nucleic acid
delivery include: polyethyleneimine (PEI) polymer [113], polyamidoamine (PAMAM)
dendrimers [114, 115], comb-like amphiphilic nanoparticles [116], etc. Recently, the
Wooley group has developed a cationic shell-cross-linked (cSCK) nanoparticle. Through
collaborative work with their lab, we have proved that cSCK nanoparticles can
effectively deliver plasmid and PNA into mammalian cells [110, 117]. In chapter three
and four, cSCK nanoparticles will be used to deliver PNA probes into living cells.
One advantage of these synthetic particles is that they can be modified to carry
multi-functional groups for various purposes. For example, to improve the serum
circulation, researchers have attached polyethylene glycol (PEG) to particles [118]. To
improve specificity in cell targeting, receptor binding ligands can be attached to particles.
This can also help the cellular uptake of the particles via receptor mediated endocytosis
[119, 120]. These particles can also incorporate agents such as fusogenic peptides that
can facilitate endosomal escape of the probes [121, 122]. Researchers have also
conjugated nucleic acid probes to the nanoparticles via bioreductively-cleavable bonds,
such as disulfide bond, which will enable the release of the probes after delivering them
into the cells and enhance the antisense effect [110]. Some polyplexes are also degradable,
making them usefully tools for clinical gene therapies and in vivo imaging [123]. Figure
1.4 depicts the general use of nanoparticles for the delivery of nucleic probes and mRNA
imaging.
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Besides cationic polymers, another type of nanoparticle used for antisense imaging
is to use gold nanoparticles. Researchers have modified the surface of gold nanoparticles
with various ligands, including single strand DNA. In one type of construct, the ODNs
are conjugated to fluorophores to form a beacon on the gold surface, The fluorescence of
the fluorophores is quenched by the gold nanoparticles and is restored when the ODNs
bind to target mRNA inside cells [124]. In other circumstances, the ODNs can hybridize
to nucleic acid probes and carry these probes into the cells [26, 125].

Figure 1.4: Schematic representation of nanoparticles mediated cellular delivery
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1.3.2.4 Other methods and chemicals for cellular delivery
There are some other techniques and methods to achieve cellular delivery of
nucleic acid probes. One method is microinjection, which uses a needle 0.5 to 5
micrometers in diameter to inject the probes into a single cell [93, 126]. This method
ensures that the probes are injected into the cytoplasm or nucleus; however, it is time
consuming and cannot be applied to large scale transfection. Another method is to use
pore forming chemicals. Studies have shown that some chemicals in the exotoxin family,
such as streptolysin O (SLO), can cause reversible pores on cell membrane [127, 128].
Studies have shown that treating certain type of cells with SLO can effectively deliver
probes into membrane and image mRNA in living cells, with minimum damage to the
cells after recovery. Another way to form pores on the membrane is through
electroporation, which uses electrical pulses to stimulate the cells and form transmembrane pores on the cell surface so that the molecular probes can enter the cytoplasm
of the cells [129, 130]. Besides the three methods mentioned above, there is another way
to load the probes called “pinocytic cell-loading” [131, 132]. This method induces
pinocytosis of the cells by treating the cells with buffer containing probes and high
concentration of glucose. After taking up the probes, cells are treated with diluted
medium (lysis buffer) that will induce the burst of the endosomes to release probes into
the cytoplasm. This method can produce homogeneous distribution of the probes inside
cells; however, such method of delivery requires high concentration of the probes, which
may be expensive to synthesize.
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1.3.3 Enhancing endosomal escape of nucleic acid probes
Another obstacle for antisense inhibition and imaging of mRNA expression is the
release of probes after delivery via endocytosis mechanisms. Although other pathways
exist for cellular delivery of nucleic acid probes, a lot of lipoplexes and polyplexes
(nanoparticles) enter into the cells via endocytosis [108]. As the endosomes form and
develop from the early stage to the late stage, the pH inside the vesicles decreases from 7
to around 5.5. Then the late endosomes fuse with lysosomes and the nucleic acid probes
are prone to be degraded in lysosomes or exported out from cells. Therefore, to achieve
better delivery efficiency, it is necessary to disrupt endosomes at early stage to release
their cargos into the cytoplasm. Researchers have developed many approaches to
facilitate the endosomal release of the cargos, however, the effectiveness of this process
remains a major problem for mRNA imaging in living cells and in vivo [133].
One way to induce endosomal escape is to use fusogenic agents, including fusogenic
lipid, peptides or proteins. For example, researchers have incorporated a fusogenic lipid
dioleoylphosphatidylethanolamine (DOPE) into polymers and found this to enhance the
delivery of nucleic acids in the polyplexes [134, 135]. Some peptides, like
haemagglutinin, will change conformation from a hydrophilic to a hydrophobic coil when
the pH drops from 7 to 5. This change causes the peptide to fuse with endosome
membranes when the endosomes acidify, which helps the cargo to pass across the
endosomal membrane barrier [136]. Another example is the influenza –derived fusogenic
peptide diINF-7, which has been shown to enhance the endosomal escape of certain
siRNAs and increase their effect on gene silencing [137].
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Another way to promote endosomal escape is by the “proton sponge” effect [138]. It
hypothesized that amine groups have certain buffering capacity between pH 7 and 5. As
an endosome acidifies, these amino groups “absorb” extra protons, buffering against
acidification and maintaining the pH at a higher level inside the endosome. This effect
induces the ATPase to “pump” in more protons into the endosome, and more counter ions
to balance the protons. The enrichment of counter ions will cause the osmotic swelling
and rupture of the endosome, causing the release of the probes. One typical polymer that
employs the proton sponge effect is polyethyleneimine (PEI), which has been widely
used for gene delivery [113, 139]. Other chemicals containing secondary and/or tertiary
amine groups such as chloroquine [140] and histidine [141], have also been used to
improve the endosomal escape of the probes.
A third way to promote endosome rupture is to use photosensitive molecules.
Photochemical internalization (PCI) is a technology designed to promote endosome
rupture and cytosol release by photosensitizers. These molecules, upon stimulation of
light, become excited and help to form reactive oxygen species, which have a very short
lifetime, and will break the endosome membranes without damaging other parts of the
living cells [142]. For example, mixing one photosensitizer, meso-tetraphenylchlorin
disulphonate (TPCS2a), together with siRNA has been proved to promote endosomal
escape of the siRNA in the human epidermoid carcinoma cell line A431 upon exposure to
light source [143].
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1.3.4 Other issues regarding antisense mRNA imaging
Despite the fast development in molecular imaging and cellular delivery of the
probes, there are still some issues calling for researchers’ attention in antisense mRNA
imaging. One of the issues is secondary structure of mRNAs. Because of their large size
and complicated structure, mRNAs usually fold differently under different conditions
[144]. The secondary structure of mRNAs have profound influence on their biological
functions [145], and can also affect antisense probe binding [146]. When selfcomplementary segments of mRNA fold together via Watson-Crick base pairing, they
may not be fully accessible to antisense probes. To design an effective antisense probe
for mRNA imaging, one needs to avoid those non-accessible sites. One tool that many
researchers use is computer-generated mRNA structure prediction software. Some of the
computational programs are based on minimal free energy (such as m-fold) and
probability of the alignment. These computational algorithms have helped researchers in
designing antisense probes [82, 128], however, they still cannot provide accurate
prediction of mRNA structure in vivo. A better approach is to determine the structure
experimentally, such as through the use of oligonucleotide probes to map the accessible
sites [147, 148]. For example, our group has successfully mapped antisense-accessible
sites on native mRNAs isolated from cells using a modified reverse transcriptase random
oligodeoxynucleotide (RT-ROL) assay called MASL. This assay has lead to the design of
siRNAs and antisense PNAs with high binding affinity to the iNOS mRNA [149]. Other
methods include RNase H cleavage mapping, and use of molecular beacons to screen for
antisense binding sites [150].
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Another challenge for mRNA imaging is the low copy numbers of mRNA inside
cells, which range from less than ten to a few thousand copies [151]. It is almost
impossible to image mRNAs with low copy number inside living cells without
amplification. In addition to RT-PCR, researchers have developed other amplification
methods to detect mRNA in vitro using nucleic acid probes. For example, researchers
have used a DNA molecular beacon to detect mRNA in solution with the assistance of
exonuclease III, which preferably digests one strand of the DNA/DNA or DNA/RNA
duplex from 3’ blunt end but not the intruding single strand. When the beacon binds to
the mRNA, they form a blunt end at the beacon’s 3’ side, but the 3’ end of the mRNA
becomes an overhang strand. Therefore the beacon is digested by the enzyme, leaving
mRNA intact and able to bind another beacon molecule. The digested beacon will release
the fluorophore and the fluorescent signal is amplified each time the enzyme digests the
DNA beacon binding to the mRNA [152]. Another design is called “invasive cleavage
assay”, which uses a sequence specific 5’ nuclease to remove the quencher from the
DNA probes after they bind to the mRNA target. The cleaved probes become
permanently fluorescent and are then replaced by intact probes. The turnover of this
process amplifies the fluorescent signal [153].
In some cases, certain mRNAs become over-expressed in cells under stimulating
conditions [154] or in cancer cells [155]. These over-expressed mRNAs are usually the
proper targets for in vivo imaging and are of crucial importance for diagnostic and
therapeutic purposes.
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1.4. Conclusion and the subjects of this thesis.
Much effort and progress has been seen in the field of mRNA imaging [27],
especially the antisense imaging using hybridization probes. Various derivatives of
nucleic acids have been developed to improve the stability of probes inside cells. New
fluorescent dyes in the near infrared region [156], quantum dots, and radioactive agents
have been incorporated to increase the sensitivity of the probes. There are also new
designs, imaging methods and instruments designed to produce reliable in vivo images
with high signal to noise ratios. Developments in nanotechnology have led to new
particles that can carry multiple functional groups for in vivo imaging purposes.
Researchers now are able to achieve multi-color multi-sites imaging by FISH [44], single
molecule sensitive imaging for RNA in living cells [157], and ratiometric quantification
of fluorescence in living cells [158]. However, there remain hurdles for mRNA imaging
in vivo. Effective cellular delivery and endosomal release of nucleic acid probes, specific
and fast hybridization of the probes, as well as sensitive and quantitative detection
methods remain to be challenging issues for researchers in this field [33].
The overall goal of this thesis was to investigate methods that can quantitatively
image mRNA in living cells, which will provide foundation for noninvasive in vivo
imaging. We have investigated several strategies to image mRNA in vitro, in situ and in
cells by using different imaging agents, including fluorescence enhancing aptamer tags,
strand-displacement activated fluorescent PNA-DNA probes, and PNA FRET probe pairs.
We have also investigated several approaches to facilitate the cellular delivery of the
probes. Although compared with some other methods such as RT-PCR, the strategies we
exploited are less sensitive for quantitatively measuring mRNA in living cells. They can
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provide researchers with spatial and temporal information of gene expression. These
studies will also help researchers to image gene expression in human by nucleic acid
probes with minimum damage, which is the ultimate goal of this research.
In chapter two, we will demonstrate a method to image a transgene RNA tagged with
an aptamer that can bind to malachite green (MG) and strongly enhance its fluorescence.
We have shown that the aptamer can bind to MG in solution and in total RNA extracted
from transgene containing cells. MG was delivered into the cells via free diffusion as
well as by the “influx” cell loading method. We have shown that by introducing MG into
the cells, we can detect the transgene inside living cells both by confocal microscopy and
flow cytometry.
In chapter three, we will show our work to image mouse inducible nitric oxide
synthase (iNOS) mRNA in RAW264.7 cells using strand-displacement activated PNA
probes. The probes consist of a 23-mer fluorescently labeled PNA hybridized to a 17-mer
complementary DNA conjugated to a quencher. The fluorescence of the duplex probe is
quenched and can only be restored upon hybridizing to the target mRNA, which causes
the shorter DNA quencher strand to be displaced. We have shown that this type of probe
can detect DNA and in vitro transcribed mRNA in solution. We have used the stranddisplacement probes to image iNOS mRNA by fluorescence in situ hybridization (FISH).
For the live cell imaging, cSCK nanoparticle was used as the delivering agent and we
have shown the fluorescent images of iNOS mRNA in mouse macrophage RAW 264.7
cells.
In chapter four, we will demonstrate the use of fluorescently labeled PNA probes to
image iNOS mRNA in living cells by FRET. We have optimized the best position for two
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FRET PNA probes to achieve the optimal FRET efficiency, and have shown that the
FRET pairs can bind to the iNOS mRNA in vitro. We then delivered the two probes into
cells by hybridizing them to the partially complementary DNAs and complexing them
with cSCK nanoparticles. FRET images of iNOS mRNA inside cells were obtained by
confocal microscope and average FRET intensity of selected regions of interests (ROIs)
were used to detect the increase of iNOS mRNA in living RAW 264.7 cells after
stimulation by lipopolysaccharide (LPS) and gamma interferon (γ-IFN).
In chapter five we will summarize our work on mRNA imaging using fluorescent
molecule and optical nucleic acid probes and propose future work in this field.
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Chapter Two
Multimeric aptamer cassettes for transgene mRNA detection by
malachite green (MG)
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ABSTRACT
The ability to tag mRNAs with functional segments in the un-translated region has
enabled a wide range of studies on behavior and distributions of specific mRNAs in
living cells. Herein we report the design and construction of repeated aptamer sequences
(cassettes) for tagging mRNA transcripts and show that they can be used to image a
transgene mRNA by the small molecule malachite green (MG), whose fluorescence
increases upon binding to the aptamer. We have shown that the aptamer in transfected
cells can be detected in the presence of MG by confocal microscopy and flow cytometry.
This multimeric cassette strategy can also be used to enhance RNA imaging by molecular
beacons, FRET probes, and fluorogenic agents.
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INTRODUCTION
Messenger RNA (mRNA) plays an indispensable role in gene expression and
protein production for most biological species. It is therefore of great interest to be able to
spatially and temporally monitor mRNA in vivo. One approach to nondestructively image
endogenous mRNA in real time is to use fluorescently or radioactively labeled antisense
probes designed to bind mRNA by Watson-Crick base pairing [1]. Because endogenous
mRNA sequences have complex secondary and tertiary structures and are also bound by
proteins in vivo, it often requires a fair amount of effort to identify high affinity antisense
binding sites suitable for mRNA imaging [2]. Even when a suitable antisense agent is
identified, there remains the challenge to obtain good signal to noise ratio as mRNAs are
usually present at very low concentration inside cells [3], making it difficult to
distinguish signals generated by specific binding from signals from free reporters and
nonspecific binding. To overcome this problem, investigators have developed binary
FRET and molecular beacon-based systems [4-6], which are designed to emit
fluorescence only upon binding to the target mRNA. Nonetheless, achieving high
sensitivity and signal to noise still remain as major problems for imaging mRNA using
nucleic acid probes [7].
Another way to image and track mRNA inside cells is to use a tagged transgene.
Unlike endogenous genes, which have a defined sequence and limited number of copies,
transgenes can be constructed to afford control over copy numbers and sequence [8-10].
For example, one way to study the behavior of mRNAs in living cells in real time is to
biosynthetically tag the mRNA of interest with multiple repeats of the MS2 coat protein
that binds to an RNA stem loop. The mRNA can then be imaged by using a cell line
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expressing an MS2 protein fused with a green fluorescent protein. In this way, the
movement of the mRNA can be monitored by observing the fluorescence of GFP [11,
12].
Instead of tagging a transgene with the MS2 protein binding sequence, one can
also tag an mRNA with multiple repeats of sequences that can bind to a fluorogenic
ligand or a nucleic acid probe. In this chapter, we will report on our work to detect a
transgene mRNA tagged with multiple repeats of an aptamer that can bind to the small
molecule malachite green (MG). Aptamers are short oligonucleotides, which are selected
from systematic evolution of ligands by exponential enrichment (SELEX) process and
can be evolved to have strong binding affinity to specific proteins or small molecules
[13]. One such RNA aptamer has been reported to have high binding affinity to malachite
green (MG), which has very low fluorescence in the unbound state due to efficient
vibrational de-excitation. However, upon binding to the aptamer, the vibrational modes of
the molecule are restricted and its charge distribution and conformation are changed [14].
As a result, its fluorescence increases up to 2000 times, making it a good reporter to
detect the RNA aptamer [15]. This MG aptamer has been adapted for the detection of
nucleic acids [16]. Similar aptamers have also been studied to bind other ligands such as
cocaine and ATP both in vitro [17, 18], and in living cells [19].
Our approach was to clone multiple repeats of the DNA sequence (cassette) coding
for the MG aptamer into the 3’-end of an expression vector for the β2-adrenergic receptor
fused with green fluorescence protein (Flag-mβ2AR-GFP). The expressed mRNA would
thereby become fluorescent in the presence of Malachite Green, while the GFP would
serve as an independent marker for expression of the transgene protein. This transgene
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was constructed by a former lab member Dr. Huafeng Fang. He was able to show that
the mRNA tagged with the repeating aptamer could be detected in a total cellular RNA
extract in the presence of MG. I will demonstrate that such a transgene can also be used
for fluorescence imaging of mRNA expression in living cells by confocal microscopy and
flow cytometry.

EXPERIMENTAL PROCEDURES
Materials
All ODNs were purchased from Integrated DNA technologies Inc (Coralville, IA),
and purified by 15% or 20% denaturing polyacrylamide gel electrophoresis, following
extraction with phenol/chloroform and ethanol precipitation. The pET-28a vector was
obtained from EMD Chemicals (Gibbstown, NJ). Flag-mβ2AR-GFP plasmid was a
kindly gift from Dr. Factor, Columbia University. All restriction enzymes were obtained
from New England Biolabs Inc (Ipswich, MA). RNA was isolated with the T7
RiboMAXTM large RNA production system purchased from Promega (Madison, WI). All
chemicals for buffers and media preparation were purchased from Sigma-Aldrich (St
Louis, MO). The cell culture media was purchased from Invitrogen Inc (Carlsbad, CA).
MDCK cells (CCL-34TM) were purchased from ATCC (Manassas, VA).

Cell culture
MDCK Cells were grown in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin (10
µg/mL). Cell cultures were maintained at 37°C, 5% CO2 incubator. G418 (200 µg/mL)

51

was added to select stable transfected MDCK cells.

Construction of the aptamer cassette-bearing vectors and transgene (Huafeng Fang)
An ODN identical to the aptamer sequence was annealed to its complementary
ODN, digested by XbaI and HindIII and cloned into a pET-28a vector that had been
cleaved by the same enzymes. Clones containing the insert were selected based on size
and verified by plasmid sequencing. The single cassette could then be excised from the
plasmid by restriction enzyme digestion with NheI and HindIII. To double the number of
cassettes, the single cassette that had been excised by NheI and HindIII was cloned into
the original plasmid that contained a single cassette that had been digested by XbaI and
HindIII. By repeating this process it is possible to generate many repeating cassettes. To
transfer a single or multiple cassette to the trans-gene vector, the appropriate pET-28a
vector was excised by XbaI and NotI and the cassette bearing fragment was separated by
polyacrylamide gel electrophoresis and ligated into Flag-mβ2AR-GFP that had been
digested by BSrG1 and NotI. The ligation part contained a BSrG1/XbaI linker
pd(GTACAAGTAAAAAAT)•pd(CTAGATTTTTTACTT). With this strategy, Flagmβ2AR-GFP-MGIII (3 repeats of the MG aptamer sequence ), Flag-mβ2AR-GFP-MGVI
(6 repeats of the MG aptamer sequence), Flag-mβ2AR-GFP-24L (24 repeats of a liner
sequence that is designed to bind molecular beacons and used as a negative control of
MG aptamer in this study) were cloned.
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Detection of in vitro transcribed aptamer cassettes in presence of cellular RNAs
(Huafeng Fang)
A triple repeating aptamer sequence was prepared by in vitro transcription from
pET-MGIII plasmid using T7 RiboMAXTM large RNA production systems (Promega
Inc.). Different amounts of the in vitro transcribed aptamer were incubated with 100 nM
MG and 1μg/ml total RNA extracted from MDCK cells for 30 min at 37 °C. The
fluorescence was taken with excitation at 633 nm and emission at 650 nm. The buffer
contained 40 U RNaseout Ribonuclease Inhibitor (Invitrogen), 0.1 M KCl, 5 mM MgCl 2 ,
10 mM Na-Hepes, pH 7.4.

Aptamer cassette expression in cells and detection of aptamer in total RNA by MG
(Huafeng Fang)
Plasmids Flag-mβ2AR-GFP-MGVI and Flag-mβ2AR-GFP (no aptamer control)
were transiently transfected into MDCK cells using Lipofectamine 2000. After 24 h, the
cells were recovered and the total RNA was extracted by TRizol reagent (Invitrogen).
Total RNA (1 µg/mL) of four different samples of cells (sample A, B were transfected
with aptamer containing plasmid and C, D with control plasmid) was incubated with 1
µM Malachite green at 37 °C, 30 min with 40 U RNaseout Ribonuclease Inhibitor
(Invitrogen), 0.1 M KCl, 5 mM MgCl 2 , 10 mM Na-Hepes, pH 7.4. Fluorescence was
quantified on a Varian Fluorimeter with an excitation wavelength at 630 nm and emission
wavelength at 650 nm.
Slot blot hybridization was used to identify aptamer cassette expression in the
transfected cells. Briefly, a Hybond-XL membrane (Amersham Bioscience) was placed
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into the slot blot apparatus (Minifold I, Schleicher & Schnell). Then 20 µg of total RNA
from each sample of cells was denatured for 5 min at 68 °C in 50% formamide, 7%
formaldehyde, and 1 × SSC (150 mM NaCl and 15 mM sodium citrate). The resulting
RNA samples were applied to the slots of the manifold. After all of the samples had
passed through the membrane, the membrane was dried and baked at 80°C for 2 h. The
membrane was then pre-hybridized with ULTRhyb-Oligo (Ambion Inc.) for 1 h at 55 °C,
then

incubated

with

[γ-32P]-ATP

labeled

ODN

probe

(dGATTCGTTACCTGGGTCTCCCCAGTCG) that was partially complementary to the
aptmer sequence. The incubation was carried out over night at 55 °C. The blot was
washed at 55 °C using 1 × SSC with 0.5 % SDS twice, 30 min for each wash, followed
by washing with 0.1 × SSC and 0.5 % SDS twice, with 10 min each time. The blot was
then exposed to a phosphorimager screen for 4 h, and scanned with a Bio-Rad
Phosphorimager.

Transgene aptamer imaging in living cells
Flag-mβ2AR-GFP-MGVI transfected cells that showed the highest expression
level of aptamers from slot blot hybridization results (sample B) were selected and were
mixed with normal MDCK cells. About 5 × 105 of the mixed cells were plated in 35 mm
MatTek glass bottom micro-well dishes and incubated with DMEM culture medium
without G418 at 37°C overnight. MG was loaded into the semiconfluent cells by InfluxTM
Pinocytic cell-Loading Reagent (Invitrogen, Inc.). The Hypotonic Lysis Medium and
Recovery Medium were pre-warmed at 37 °C. After removing the medium from the
plate, the cells were incubated in the Loading Medium containing 10 µM MG for 10 min
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at 37°C. The Loading Medium was then removed and the cells were washed and
incubated with lysis medium. After 2 min the lysis medium was removed and fresh
medium (2 mL) was added, and the cells incubated at 37 °C, 5% CO 2 for another 2 h.
Cells were then washed twice with PBS and the fluorescence images of the live cells
were taken with a Zeiss confocal microscopy with excitation by a He-Ne (633 nm) laser.

Detection of MG aptamer in living cells by flow cytometry
In order to quantitatively compare the aptamer binding triggered fluorescence in
cells, we used flow cytometry to collect the fluorescence of MG with excitation at 633
nm (Becton Dickinson FASCan) and the data were processed by FlowJo 8.84 software.
Two methods for delivering MG into living cells were used. One was the influx
method as described previously. MDCK cells and cells transfected with Flag-mβ2ARGFP-MGVI were grown in 6 well plates at 1×105 per well. When cells grew to 80%
confluence after 48 h, they were treated with 300 µL loading buffer containing 10 µM
MG for 10 min, followed by 2 min treatment with lysis buffer. The cells were then
incubated in DMEM medium with serum for 2 h, digested by trypsin/EDTA, and filtered
for flow cytometry.
In another set of experiments, MG was delivered into living cells by free diffusion.
Wild type MDCK cells and cells that stably expressed Flag-mβ2AR-GFP-24L or Flagmβ2AR-GFP-MGVI gene were seeded in a 6-well plate at 1×105 per well. When the cells
grew to 80% confluence after 48 h, the media was changed to PBS solution containing 5
µM MG and the cells were incubated for an additional 2 h. The cells were then washed
with PBS 3 times, and then incubated with fresh media for another 2 h or 24 h at 37°C
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to let the excess MG molecules efflux from the cells. After the treatment, cells were
digested with 0.05% Trypsin/EDTA, re-suspended in PBS buffer and filtered for flow
cytometry.

RESULTS AND DISCUSSION
In the study herein we chose the MG binding aptamer (Figure 2.1A) as an mRNA
because it has been reported previously to bind to MG with high affinity, and enhance its
fluorescence by over 2000-fold [15]. Dr Huafeng Fang of our group had successfully
constructed the Flag-mβ2AR-GFP-MGVI plasmid and transfected it into MDCK cells
(Figure 2.1B). He also cloned a linear sequence that was devoid of secondary structure
that could be used for antisense probes (Flag-mβ2AR-GFP-24L, Figure 2.1B). For the
details of Flag-mβ2AR-GFP-24L transgene imaging using molecular beacons, please
refer to the thesis of our former lab member Dr. Bereket Oquare.

Creation of multiple cassettes
Multiple repeats of the aptamer and antisense cassettes were created by an
iterative cloning procedure [20] shown in Figure 2.2. First, a 61-mer DNA sequence
containing MG aptamer coding gene, Xba I, Nhe I and Hind III restriction sites was
prepared by automated DNA synthesis. Xba I and Nhe I were chosen because they can
produce the same 5'-sticky end following cleavage while having different recognition
sequences. In the first step of the cycle, the 61-mer was digested by Xba I and Hind III
and cloned into a pET-28a vector that had been cleaved at the same sites. The presence of
the insert was verified by sequencing. To add a second aptamer /cassette, the clone was
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cleaved instead by Nhe I and Hind III followed by insertion of another aptamer sequence.
Because the cleavage sites of Xba I and Nhe I share the same 5'-sticky end, they can be
ligated together, rendering a sequence that is neither cleavable by Nhe I or Xba I. The
double insert can then be excised by treatment with Xba I and Hind III and inserted back
into the another clone that contains one insert to generate a 3-mer repeat, or back into the
another clone with two inserts to generate a 4-mer repeat. This recycling strategy enables
one to increase the number of the insert exponentially.

Cloning antisense repeats into the 3'-UTR of a transgene
As part of a research project to develop agents for monitoring the transcription of
a therapeutic gene for the treatment of acute lung injury (ALI) in vivo, we cloned the
multimeric antisense cassettes into the 3'-UTR of a flag-tagged β2-adrenergic receptor
fused to EGFP (Figure 2.2). Transgenic overexpression of the β2-adrenergic receptor has
been shown to increase the rate of alveolar fluid clearance in mouse [21] and improve the
survival rate of mice with ALI [22]. The multiple repeating inserts were first excised
from the pET28a vector by Xba I and Hind III. The repeats were then cloned into the
Xba I site of the transgene following the EGFP coding region with a linker sequence
(Figure 1B). We were able to produce and characterize the clones containing 6 repeating
aptamer sites. These vectors could be used for transient expression of the aptamer, and to
produce stably transformed MDCK cell lines for imaging studies by selection for G418
resistance. The presence of the aptamer cassette was confirmed by a dot blot experiment.
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Detection of in vitro transcribed aptamer cassettes in the presence of cellular RNAs
First, we tested the ability of MG to detect different concentrations of in vitro
transcribed aptamer in the presence of competing total RNA from cell extract (Figure
2.3). The three repeating aptamers were incubated with 100 nM MG and 1 µg/µl cellular
total RNA extracted from MDCK cells at a final concentration of 100 nM, 10 nM and 1
nM respectively. The fluorescence was observed at an excitation wavelength of 630 nm
and emission wavelength of 650 nm. We found that the fluorescence of 100 nM
aptamer/MG complexes in the presence of 1 µg/µL of RNA was about 22 times higher
than the MG alone in the absence of the aptamer. When the aptamer concentration
decreased to 1 nM, we could still observe the signal to be 2 fold stronger than the control,
indicating that MG is a sensitive probe to detect the presence of the aptamer in vitro.

Aptamer cassette expression in cells and detection of aptamer in total RNA by MG
We then examined the possibility of using MG to detect the aptamer labeled
mRNA in total mRNA extracts isolated from various transformed cell lines (Figure 2.4).
Four different colonies of cells were selected. Samples A and B were transfected cells
and C and D were normal MDCK cells. Total RNA from each of the samples was
extracted and was tested for the presence of the aptamer by dot blotting. The upper right
panel in Figure 2.4 shows the intensity of aptamer expression level measure by the dot
blot. The fluorescence spectra of the MG in different RNA samples confirmed the
difference in expression level of the aptamer in four samples. Sample E is a negative
control which contains only buffer and MG. The fluorescence from the cell extracts
expressing the aptamer (A and B) were 1.5 to 2.5 times greater than that of those not
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expressing the aptamer (C and D), indicating that MG can be used to detect aptamer in
the presence of competing RNA in vitro.

Fluorescence imaging studies of living cells
Malachite green is a small molecule and is much more cell membrane permeable
than nucleic acids. MG can diffuse into cells without the assistance of other agents for
delivery. The influx approach, on the other hand takes advantage of pinocytosis to
introduce cargo into endosome within cells, and hypotonic shock to rupture the
endosomes to release the encapsulated cargo into the cytoplasm [23]. The Influx system
was used in this experiment because we wanted to use a universal method that could
deliver MG into living cells as well as antisense nucleic acid probes which are otherwise
membrane impermeable. Based on the above considerations, we used the Influx system to
deliver MG into a mixture of MDCK and Flag-mβ2AR-GFP-MGVI transfected MDCK
cells, which transiently express the six-repeating aptamer and the membrane associated
AR-GFP. Confocal microscopy showed that blue fluorescence from the MG/aptamer colocalizes with cells expressing green fluorescence from the EGFP (Figure 2.5). This
means that transfected cells expressing AR-GFP have the mRNA transcripts and aptamer
binding sites, which will render stronger MG fluorescence. The co-localization pattern
shows that MG can be used effectively to image the transfected cells expressing MG
aptamer.

Fluorescence measurement by flow cytometry
To quantitatively measure the difference in aptamer expression for different types
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of cells, we used flow cytometry to monitor the fluorescence of MG in living cells. We
used two methods to deliver MG inside cells, one via influx and the other by free
diffusion. In the influx delivery method, cells were treated in the same way as for the
confocal microscopy study described above. For the Flag-mβ2AR-GFP-MGVI transgenic
MDCK cells there are two populations: GFP positive cells and GFP negative cells. For
cells expressing high level of GFP, the mean fluorescence was higher than those that
didn’t express GFP (Figure 2.6 A, B). This confirms the results observed in the confocal
microscopy study. The mean fluorescence for of MG for GFP positive cells, however,
was only 1.33 fold higher than that of wild type MDCK cells under the same influx
delivery conditions (Figure 2.6 C, D).
To further confirm our findings, we also delivered MG into cells by free diffusion.
Since MG has a certain level of toxicity [24], the concentration and incubation time
needed to be carefully optimized in order to keep cells viable. We optimized the
conditions and found that incubation with 5 µM MG for 2 h can results in the most
efficient MG delivery with the minimum cytotoxicity. MDCK and Flag-mβ2AR-GFPMG24L transfected MDCK cells were used as negative controls. All the cells were
incubated until 80% confluence, treated with 5 µM MG for 2 h, washed to remove excess
MG, and incubated in the media for an additional 2 h or 24 h after the removal of the
MG. Figure 2.7 A shows the mean fluorescence of cells that were not incubated with
MG. Figure 2.7 B shows the cell fluorescence after 2 h incubation post MG treatment.
Each type of cells has almost the same amount of MG fluorescence. This may be because
of overloading the MG molecules, which would then outnumber the aptamers that can
bind to them. After 24 h of incubation, cells without the MG aptamer cannot trap MG
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inside the cells and MG molecules could exit the cells. The Flag-mβ2AR-GFP-MGVI
MDCK cells, on the other hand, have the aptamer that can bind to the MG molecules and
show higher fluorescence. This was reflected clearly in Figure 2.7 C showing that after
24 h of incubation post MG treatment, Flag-mβ2AR-GFP-MGVI transfected MDCK
cells have higher mean fluorescence than the rest of the cell samples. Figure 2.7 D shows
the increase of fluorescence for each type of cell at 24 h incubation after removal of MG
compared to cells not treated with MG. The mean fluorescence of the Flag-mβ2AR-GFPMGVI MDCK cells is 1.27 fold higher than that of normal MDCK cells, which confirms
our finding by influx method. Compared to free diffusion, the influx method used higher
amount of MG (10 μM vs 5 μM), but for a less incubation time (10 min vs 2 h).
Therefore the MG molecules delivered inside cells might be less. This could explain the
fact that after 2 h of incubation post the influx delivery, the aptamer containing cells
show higher fluorescence than the wild type MDCK cells, whereas cells undergoing free
diffusion had to be incubated for a longer time (24 h) to show the similar difference in
fluorescence.
Although the aptamer-MG binding shows a clear increase of fluorescence in vitro
(around 22 times in our experiment), the difference in fluorescence between cells
expressing and not expressing the aptamer is not very large (around 1.3 times). This may
be attributed to a large excess of non-specifically bound MG remaining inside the cells. If
one assumes that the ratio of unbound and bound MG molecules was 10:1 and the
fluorescence of MG increases 22 times upon binding to the aptamer (as observed in
vitro), then the signal to noise ratio would be predicted to be 2.2:1 for aptamer expressing
cells. Thus, overloading of the MG probe may be a major problem that affects the signal
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to noise ratio in mRNA imaging with the MG aptamer. Theoretically, a longer incubation
time will allow more MG molecules to exit cells, which would improve the signal to
noise ratio. However, MG is also toxic and can produce radicals that will damage DNA
and the aptamer [25], which would not be desirable for imaging.

CONCLUSION
We have successfully constructed a transgene that is tagged with a multiple
repeating MG binding aptamer. We have shown that this aptamer can be detected using
MG in vitro and in total RNA extracted from transfected cells. We have also shown that
MG can be used to detect the aptamer in living cells by confocal microscopy and flow
cytometry.
Tagging the 3'-UTR of genes with a universal repeating target antisense cassette is
potentially a useful approach to achieve sensitive detection of genes in vitro and in vivo.
We have shown that a transgenic mRNA linked to an aptamer can be detected by a small
molecule fluorescent probe. One of the advantages of the small molecule aptamer
imaging system is that small molecules are much more membrane permeable than the
antisense agents. Unfortunately, the fluorescence of transfected cells is only 1.3 times
higher than that of wild type MDCK cells in the presence of MG. Malachite green may
not be the best choice, however, as it is also known to generate free radicals that can
damage DNA and aptamer [25]. Aptamers could be evolved to bind other desired probes
with optimal membrane permeability and fluorescent properties.
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Malachite green

Figure 2.1A: Structure of MG, MG binding aptamer and the MG binding scheme
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Figure 2.1B: Sequences used to generate the aptamer, the linear repeats, and the
linker for insertion
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Figure 2.2: Repetitive cloning strategy used to generate multimeric aptamer
cassettes
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Figure 2.3: Aptamer-specific fluorescence in presence of total cellular RNA. Three
different concentrations of in vitro transcribed three repeating aptamer RNA was
incubated with 100 nM MG in presence of 1 μg/μL total RNA from MDCK cells at room
temperature. Buffer: 0.1 M KCl, 5 mM MgCl 2 , 10 mM Na-Hepes, pH 7.4. Excitation:
630 nm.
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Figure 2.4: Detection of MG aptamer in cell extracts. MG: 1 µM, buffer: 0.1 M KCl, 5
mM MgCl 2 , 10 mM Na-Hepes, pH 7.4, total RNA 1 µg/µl, extracted from cells
expressing the Flag-mβ2AR-MGVI cassettes or Flag-mβ2AR. A: Flag-mβ2AR-MGVI1, B: Flag-mβ2AR-MGVI-2, C: Flag-mβ2AR-1, D: Flag-mβ2AR-2, E: buffer without
RNA. Excitation wavelength: 630 nm. RNA Slot blotting hybridization , [γ-32P]-ATPlabeled MG probe was hybridized with 20 µg A, B, C, D, E sample (same as above)
overnight, aptamer expression is higher in sample B.
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Figure 2.5: Aptamer cassette induced fluorescence of malachite green in cells. MG
was loaded into cells using the Influx pinocytic reagent. Fluorescence was observed 2h
later after loading. Mixture of MDCK & MDCK-Flag-mβ2AR-MGVI cells were cultured
in the same plate. A: cell reflection photo, B: green, EGFP (ext: 488 nm), C: blue,
aptamer/MG (ext: 633 nm) D: Superposition of B&C.
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Figure2.6: Flow cytometric measurement of the MG fluorescence in transfected and
wild type MDCK cells treated by influx. A. Mean MG fluorescence of (a) GFP positive
transfected cells and (b) GFP negative transfected cells; B,GFP fluorescence of the
MDCK-Flag-mβ2AR-MGVI transfected cells. The clear binominal distribution of GFP
fluorescence indicating that some cells might have expressed the transgene while some
might not; C, Mean MG fluorescence of (a) GFP positive transfected cells and (c) normal
MDCK cells after influx delivery; D, Mean MG fluorescence of (a) and (c) cells.
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Figure 2.7: Flow cytometric measurement of MG fluorescence in transfected and
wild type MDCK cells treated by free diffusion. (a). MDCK-Flag-mβ2AR-MGVI,
(b)MDCK-Flag-mβ2AR-24L, (c) wild type MDCK,. Incubated with 5µM MG for 2
hours, washed, and added fresh media incubation for another 2 or 24 h respectively. A.
Cells not treated with MG; B, 2 h incubation after MG delivery; C, 24 h incubation after
MG delivery; D, Mean fluorescence increase of three type of cells after 24 h incubation
post MG delivery. Fluorescence intensity was an average of three repeats for each type of
cells.
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Chapter Three
Strand-displacement activated Peptide Nucleic Acid (PNA) probes for
imaging inducible nitric oxide synthase (iNOS) mRNA in living cells
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ABSTRACT
Inducible nitric oxide synthase (iNOS) is an enzyme that catalyzes the production
of nitric oxide in many eukaryotic species. iNOS expression is upregulated in
inflammation, making it a good biomarker for monitoring injured tissue. We have
investigated the use of strand-displacement activated fluorescent probes to image the
expression of iNOS mRNA in living cells. The probes are constructed by annealing an
antisense PNA bearing a fluorescein to a shorter DNA sequence bearing a Dabcylplus
quencher, which quenches the fluorescence of the fluorescein. In the presence of the
target mRNA, however, the mRNA will bind to the complementary PNA strand and
displace the shorter DNA sequence, thereby restoring fluorescence of the fluorescein. We
have designed and synthesized probes that are stable at 37 oC and undergo stranddisplacement in the presence of a complementary DNA, and with in vitro transcribed
iNOS mRNA in solution. We have also investigated the ability of the probes to detect the
expression of iNOS mRNA in both fixed and living RAW 264.7 cells.
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INTRODUCTION
Nitric oxide synthases (NOS) are a family of enzymes that catalyze the production
of nitric oxide (NO) in many eukaryotic species. NO is a small molecule involved in
signal transduction and immune responses. There are three types of nitric oxide synthases
in most eukaryotic species: endothelial NOS (eNOS), neuronal NOS (nNOS) and
inducible NOS (iNOS) [1, 2]. iNOS is involved in immune responses and is upregulated
by environmental stimuli such as gamma interferon (γ-IFN) or lipopolysaccharide (LPS)
[3-5]. The mechanism of γ-IFN and LPS triggered iNOS production has been well
studied [6] and the inhibition of iNOS has been proved to be beneficial for curing
inflammatory diseases [7]. Research has been conducted on lowering NO production by
certain drugs that inhibit the protein [3, 4]. Another approach would be to inhibit mRNAs,
such as the iNOS mRNA [8-10]. Meanwhile, iNOS mRNA can also be an important
biomarker for cells or tissues in inflammatory conditions. It may therefore be worthwhile
to be able to detect, quantify, and image iNOS mRNA in vivo for clinical applications.
One way to detect and quantify iNOS mRNA expression is by RT-PCR, which can
detect mRNA at as low as a few copies per cell [11, 12]. However, this method requires
lysis of cells or tissues, and would not be applicable for monitoring iNOS mRNA in vivo.
Another way to monitor iNOS mRNA would be to use labeled antisense nucleic acid
probes, which have been used to detect mRNAs both in vitro and in vivo. Antisense
probes are complementary to the target mRNA and achieve their specificity by A-T and
C-G Watson Crick base pairing. They can be radioactively or fluorescently labeled, and
used for non-lethal, real time imaging of mRNA in vivo [13-16].
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To reduce the background, nucleic acid probes have been designed to be
fluorescent only in the presence of target mRNA. One class of such activatable probe
designs is the quenched strand-displacement probe. In this design, an antisense probe is
labeled with a fluorescent dye, whose fluorescence is quenched by a quencher attached to
a shorter complementary oligonucleotide annealed to the antisense strand. The quenching
mechanism can be by FRET, in which case the energy of the excited fluorophore is
transferred to a quencher through space [17]; or by “contact quenching”, in which a
fluorophore and a quencher are close enough that they can form a non-fluorescent
complex [18]. In the presence of the complementary target mRNA, which will form a
more stable duplex, the shorter strand is displaced, and the fluorescence of the dye on the
longer strand is no longer quenched, leading to the recovery of fluorescent signal. The
rate of strand-displacement depends on the difference in length between the fluorescent
and quenching probes. The larger the difference, the longer the un-paired section and the
faster the rate for displacing the shorter strand by the target mRNA [19].
There are a few studies utilizing the strand-displacement probes. Hnatowich et al
used a heterodimer consisting of a 25-mer phosphorodiamidatemorpholino (MORF)
conjugated to a Cy5.5 and a complementary 18mer cDNA conjugated to a BHQ3
quencher to image a complementary 25mer biotinylated MORF oligomer immobilized on
streptavidin polystyrene microspheres that had been planted intramuscularly into a mouse
[20]. The same group have also utilized a probe consisting of a 25mer phosphorothioate
DNA bearing Cy5.5 and a 10mer complementary phosphodiester DNA with BHQ3
quencher to image the multi drug resistance gene (mdr1) mRNA in mice bearing the KBG2 tumor, which over-express the mdr1 mRNA, [21]. Meanwhile, Mirkin et al.
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synthesized “nano flares” which consist of gold nanoparticles with single strand ODNs
conjugated to the surface that are hybridized to a shorter strand of complementary ODN
bearing a Cy5 quenched by the gold. In the presence of complementary mRNAs, the
shorter strand was displaced, releasing the Cy5 bearing DNA, whose fluorescent signal
could be detected. They reported that such “nano flares” can be used to detect specific
mRNAs in living cells [22]. However, in this design, the fluorescent reporter was on the
shorter reporter, which was displaced, and became free inside cells, so that the
fluorescent image could not indicate the location of the mRNA. A better design would
have been to place the fluorophore on the probe that will hybridize to the target mRNA so
that the fluorescent signal will indicate the location and distribution of the mRNAs in
inside cells.
Based on these reported studies, we utilized the strand-displacement activated
probes to detect the iNOS mRNA in vitro, in situ, and in living cells. We have
synthesized 23-mer peptide nucleic acid (PNA) probes bearing a fluorescein (FAM) at 5’
end, whose fluorescence is quenched by a Dabcylplus, which is attached to the 3’ end of a
17-mer complementary DNA probe. We have demonstrated that such stranddisplacement activated probes can be used to detect both a complementary 21-mer target
DNA and in vitro transcribed iNOS mRNA in solution. We have also employed such
strand-displacement probes to image the iNOS mRNA in fixed RAW 264.7 cells by
fluorescent in situ hybridization (FISH). We have investigated the possibility to deliver
such probes into living RAW 264.7 cells by cationic shell-cross-linked knedel-like
(cSCK) nanoparticles and image the iNOS mRNA in living cells (Figure 3.1). Analysis
of the FISH image indicated that there was 3.6 (±1.8)-fold increase of fluorescence for
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cells treated with LPS/γ-IFN compared to the non-treated cells, while the live cell
imaging results showed 16.6 (±7.9) -fold increase in fluorescence for cells after LPS/γIFN stimulation.

EXPERIMENTAL PROCEDURES
Materials
Anhydrous N,N-dimethylformamide (DMF), diisopropylethylamine (DIPEA),
trifluoroacetic acid (TFA), meta-cresol, dichloromethane (DCM)., N-methylpyrrolidone
(NMP), dimethyl sulfoxide (DMSO), (5,6)-fluorescein-N-succinimidyl ester (FAM-NHS
ester) were purchased from Sigma-Aldrich (St Louis, MO). Dbacylplus-N-succinimidyl
ester (Dabcylplus-NHS) was purchased from Anaspec Inc (Fremont, CA). PNA monomers
were purchased from PolyOrg Inc (Leominster, MA). Fmoc protected amino acids were
purchased from EMD chemicals (Gibbstown, NJ). 2-(1H-7-Azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate (HATU) was purchased from
GenScript (Piscataway, NJ). Fmoc-PAL-PEG-PS resin for the solid phase PNA synthesis
was purchased from Applied Biosystems (Carlsbad, CA). The PNAs were synthesized by
solid-phase Fmoc chemistry on an Expedite 8909 DNA/PNA synthesizer on a 2 µmol
scale. All the oligodeoxynucleotides (ODN) and amino-modified ODNs were purchased
from Intergrated DNA technologies (Coralville, IA). The crude PNA probes and the
modified DNA probes were purified by a reversed phase high-performance liquid
chromatography (HPLC) on a Beckman Gold System with a UV array detector and a
Varian Microsorb-MV column (C-18, 5µm, 300Å pore size, 4.6×250 mm internal
diameter and length). For the PNA probes, the running buffer A contains 0.1% TFA in
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water and B contains 0.1% TFA in acetonitrile. For the DNA probes, the running buffer
A contains 50 mM triethylammonium acetate (TEAA) in water and B contains 50 mM
TEAA in water/acetonitrile (1:1) solution. The purified probes were verified by
AppliedBiosystems 4700 MALDI-TOF mass spectrometry. The concentration of all the
DNAs was determined from the absorbance at 260 nm taken on a Bausch and Lomb
Spectronic 1001 spectrophotometer. To determine the PNAs’ concentration, solutions
were heated to 70 oC to eliminate the hypochromicity of the PNAs, after which the
absorbance was measured at 260 nm on the same spectrophotometer. The concentration
was then calculated based on Lambert-Beer Law 𝐴 = 𝜀𝑙𝑐, where A is the absorbance of

the solution at 260 nm, 𝑙 is the length of the light path (1 cm), and 𝜀 is the extinction

coefficient of the probes. For each DNA oligo, 𝜀 was provided by the manufacturer. For

the PNA probes, 𝜀 of each base was estimated at (A) 13.7 ml/μmol•cm, (G) 11.7 ml/
μmol•cm, (C) 6.6 ml/ μmol•cm and (T) 8.6 ml/ μmol•cm.

PNA-Fluorescein synthesis and purification
A 23-mer PNA probe antisense to the bases starting at the 480 position of iNOS
mRNA (480 PNA-FAM) and a control probe with the same length but targeting HeLa
pLuc 705 cell’s splicing correction site (pLuc PNA-FAM) were synthesized on an
Expedite 8909 DNA/PNA synthesizer. After removal of the Fmoc protecting group at the
5’ end of the PNA, the resin was dried by nitrogen gas and was mixed with 200 µL of
0.02 M FAM-NHS ester (2 eq) in DMSO, together with 2 eq DIPEA. The mixture was
put on a shaker overnight at room temperature. The resin was then washed with DMF and
then DCM, and dried under nitrogen. The resin was then cleaved in 250 µL TFA/m-
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cresol (4:1) mixture for 2-4 h. The cleavage mixture was separated from the resin. PNAs
were precipitated by adding 1 mL cold diethyl ether, and centrifuged down for 10 min.
The product was dried on a hot block at 55 oC and dissolved in water containing 0.1%
TFA. The crude products were purified by HPLC and the masses of the purified products
were confirmed by MALDI mass spectrometry.

DNA-Dabcyl plus synthesis and purification
Regular and 3’-end modified ODNs were purchased from IDT Inc. The 17-mer
quencher ODNs were modified with a (CH 2 ) 6 –NH 2 group at the 3’-end. They were
complementary to the 23-mer 480 PNA-FAM and pLuc PNA-FAM probes. These
modified ODNs were purified by HPLC. Each purified ODN (50 nmol) was reacted with
10 eq of Dabcyl plus-NHS ester in 10 mM Na 2 CO 3 /NaHCO 3 buffer, the pH of which
was adjusted to 8.5 by adding drops of 1 M hydrogen chloride. The reaction was carried
out overnight on a shaker. Then the reaction mixture was separated by gel electrophoresis
on a 20% polyacrylamide gel. Bands containing DNA-Dabcylplus were cut from the gel
and eluted in diffusion buffer containing 0.5 M ammonia acetate, 10 mM MgCl 2 , 1 mM
EDTA and 0.1% SDS. The purified products were precipitated by adding 3 volumes of
ethanol and spinning down in a centrifuge for 30 min after cooling to -20 oC for 30 min.
The Dabyclplus-DNA quencher probes were characterized by MALDI.

In vitro mRNA transcription
The PCMV-SPORT6 vector containing the iNOS mRNA gene was purchased
from American Type Culture Collection (ATCC, Manassas, VA). LB media was
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inoculated with E.coli containing the vector at 37 oC for 18 h. The plasmid was extracted
from the E.coli by using HiPure Plasmid Maxprep kit (Invitrogen). The plasmid was then
digested by Xhol (Promega) enzyme to form a linear DNA, which was purified by phenol
extraction, ethanol precipitation and was characterized by electrophoresis on a 1%
agarose gel stained with ethidium bromide. The linear DNA was then transcribed into
iNOS

mRNA

by

RiboMAX™

SP6

large

scale

RNA

transcription

kit

(Promega) following the manufacturer’s protocol. The integrity of iNOS mRNA was
verified on the 1% w/v agarose gel. All the aqueous solution in this process was prepared
by water treated with diethyl pyrocarbonate (DEPC) and the mRNA was stored at -80 oC
in water with 2 μL (80 U) RNaseOUT™ recombinant RNase inhibitor (Invitrogen).

Displacement by complementary DNA in solution
PNA-FAM (0.5 µM) and complementary ODN or DNA-Dabcylplus (1µM ) were
heated at 95 oC for 3 min in a buffer containing 100 mM Tris, 5 mM MgCl 2 , and
annealed at room temperature.. Different amounts of the 21-mer complementary ODN
were added to make the final concentration of 0.25, 0.5, 1, and 5 µM. The stranddisplacement rate was monitored at 37 oC by measuring the fluorescence increase at 525
nm as a function of time on the fluorimeter with the excitation at 488 nm. After the
fluorescent intensity reached its maximum value, each sample was then incubated at for
another 15 min and the fluorescent emission spectrum was collected with excitation at
488 nm.
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Displacement by in vitro transcribed mRNA
To test the ability of the probes to be displaced by mRNA without secondary
structure, PNA-FAM and DNA-quencher probes (matched and mismatched) were
annealed in 0.1 M KCl, 5 mM MgCl 2 , 10 mM Na-Hepes buffer (pH=7.11) The final
concentrations of the PNA-FAM and the DNA-Dabcyl plus probes were 0.2 and 0.4 μM
respectively. In vitro transcribed iNOS mRNA was added to the solution to make the
final concentration at 0.1, 0.2 and 0.4 μM respectively. Then the mixtures were heated at
65 ⁰C for 1 min and incubated at 37 ⁰C for 15 min. The fluorescence spectra of the

samples were collected at 37 ⁰C with excitation at 488 nm. All the solution in the

experiment was prepared with DEPC treated water..

To study the kinetics of the strand-displacement with mRNA under physiological
conditions, different amounts of mRNA were prepared in 10 mM Tris buffer (pH 7.15) to
make final concentrations of 0.025, 0.05, 0.1 and 0.25 µM respectively. The mRNA
solution was heated at 65 oC for 1.5 min and cooled at 37 oC, and then 1 μL
RNaseOUT™ (40 U, Invitrogen) was added to each RNA sample. The pre-hybridized
PNA-FAM/DNA-Dabcylplus (1:2) solution (1 µM for PNA-FAM probe) was added to the
mRNA solution to make the final concentration of the PNA-FAM probes at 0.05 µM.
The fluorescence of the sample was monitored by Varian Eclipse Fluorimeter at 37 oC as
a function of time. All the aqueous solution was prepared by water treated with DEPC.

q-RT PCR to quantify iNOS mRNA copy numbers in RAW 264.7 cells

RAW 264.7 cells were seeded on 10 mm Petri dish plates (Corning Inc, Lowell,
MA) and grown until 70% confluence. Different sample plates were then treated with 1
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µg/mL LPS and 300 ng/mL γ-IFN for 18, 6 and 0 h (without LPS and γ-IFN stimulation)
respectively. Cells in each plate were counted by hemocytometer and spun down in a
centrifuge. Total RNA of each sample was then extracted by TRizol reagent (Invitrogen,
CA) following the manufacturer’s protocol and quantified by measuring UV absorbance
at 260 nm. After treatment with Turbo DNase (RNase free), 0.5 µg of each total RNA
sample was reverse-transcribed into cDNA using SuperScript™ II reverse transcriptase
(Invitrogen), following the manufacture’s procedure. Briefly, 0.5 µg of each total RNA
sample was mixed with 300 ng random primers and 1 μL dNTP (10 mM each) to make a
solution of 12 μL. The mixture was incubated at 65 oC for 5 min and quickly chilled on
ice. Then 4 μL 5X first strand buffer, 2 μL 0.1 M DTT and 1 μL RNaseOUT™ were
added and the mixture was incubated at 25 oC for 2 min. Then 1 μL of the SuperScript™
II RT was added to the mixture, incubated at 25 oC for 10 min and then at 42 oC for
another 50 min. The reaction was inactivated at 70 oC for 15 min and the cDNA product
was diluted 2500 fold for RT-PCR reaction. To generate the cDNA standard, 0.5 µg
mRNA prepared previously was reverse transcribed into cDNA using the same kit with
exactly the same procedure. The resulting cDNA product was diluted in tenfold series.
The cDNAs and standards were then mixed with Power SYBR Green RT-PCR master
mix (Invitrogen) and the RT-PCR was performed on a Steponeplus™ real-time PCR
system with the following profile: 1 cycle of 50 oC for 2 min, 95 oC for 15 min, then 40
cycles of 95 oC for 15 s, 60 oC for 30 s, and 72 oC for 45 s. The primer used to amplify
iNOS

cDNA

were

d(TGGTGGTGACAAGCACATTT)

and

d(AAGGCCAAACACAGCATACC), and for the GAPDH cDNA, the primers were
d(TGGAGAAACCTGCCAAGTATG) and d(GTTGAAGTCGCAGGAGACAAC). Each
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well contained 25 μL reaction mixtures including 2.5 μL forward primer, 2.5 μL reverse
primer, 2.5 μL double distilled water, 5 μL cDNA template and 12.5 μL Power SYBR
Green RT-PCR master mix. The threshold cycle C T was automatically set by the machine.
Standard curve method was used to determine the absolute copy number of the iNOS
mRNA in cells. Comparative C T (ΔΔC T ) was used to calculate the relative increase of the
iNOS mRNA level compared to the GAPDH mRNA.

Strand-displacement by iNOS mRNA using fluorescent in situ hybridization (FISH)
Raw 264.7 cells were seeded in glass bottom plate (14 mm) at 105 per well, and
cultured overnight in DMEM (without phenol red) containing 10% FBS, streptomycin
(100 µg/mL) and penicillin (100 units/mL) at 37˚C in a humidified atmosphere with 5%
CO 2 . Samples were then divided into treatment group and control group. Cells in the
treatment group were stimulated with 1 µg/ml LPS and 300 ng/ml γ-IFN, and cultured for
another 18 h. Cells in the control group were incubated for 18 h without stimulation.
Cells in both groups were washed with PBS twice and fixed in solution containing 4%
formaldehyde, 5 % acetic acid 0.9 % sodium chloride at 37 oC for 10 min. The fixed cells
were then washed with PBS and treated with 0.1 % triton X-100 in PBS for 5 min. The
samples were then washed with PBS once, post fixed with 3% formaldehyde in PBS
solution for 5 min, and washed with 2X SSC twice. After that, cells were dehydrated with
series of ethanol (70%, 80%, 90%, and 100%) and air dried. Samples were then incubated
with 150 µL Na-Hepes solution containing 0.2 µM matched or mismatched PNA-FAM/
DNA-Dabcylplus (1:2) probes for 60 min at 37 oC, washed with 2X SSC. The fluorescence
of the samples was then observed by Nikon A1 confocal microscope. The fluorescent
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images were processed by image J software. The mean fluorescence per cell is calculated
by integrating the signal intensity of the regions of interest, then having it divided by the
number of cells in the regions of interests.

Strand-displacement by mRNA in living cells
RAW 264.7 cells were seeded on 10 mm glass bottom dish (MatTek) at 5 x 104 per
well and incubated overnight until they were 70% confluence. The cells were then
washed with PBS and incubated in 1 mL media containing 1 µg/mL LPS, 0.3 µg/mL γIFN for 18 h at 37 ˚C in a humidified atmosphere with 5% CO 2 . As for the control, cells
were incubated under the same conditions without LPS and γ-IFN. Matched and
mismatched PNA-FAM/DNA-Dabcylplus (1:1.25) probes were annealed in 25 µl OPTIMEM for each sample and mixed with cSCK nanoparticles. The mixture was incubated at
room temperature for 20 min to let the cSCK associate with PNA-FAM/DNA-Dabyclplus
and was added to 75 µl DMEM medium containing 10% FBS and without antibiotics.
Cells were then washed with PBS and incubated with the 100 µl medium containing the
cSCK complexes. To keep inducing the iNOS mRNA, LPS and γ-IFN were added at 1
µg/mL and 0.3 µg/mL concentration respectively. The final concentration of the PNAFAM and the DNA-Dabcylplus in each sample solution was 0.4 µM and 0.5 µM. The
concentration of cSCK was 9.7 µg/ml. The N/P ratio, which is the number of amines
(positive charges) on the nanoparticles over the number of phosphate groups (negative
charges) on the DNA backbone was 8:1. After 24 h of incubation, the fluorescent images
of the cells were collected by Nikon A-1 confocal microscope. The fluorescent images
were processed by image J software and were undertaken the same analysis as for the
ones in the FISH experiment.
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RESULTS AND DISCUSSION
Sequence design and synthesis of the PNA-FAM probes
PNA is a DNA analog that has a peptide backbone. Compared to regular DNA, it has
many advantages, such as higher affinity to a complementary strand, greater resistance to
many enzymes, and better specificity for targets [23]. Therefore, it is a good probe for
antisense binding and imaging. Because PNA is a neutral molecule, it has poorer water
solubility compared to DNA. We have designed a 23 base pair PNA which is antisense to
iNOS mRNA position 473-494 (with one base at 5’ end mismatched to the mRNA)
(Table 3.1). The sequence was selected according to our lab’s published results on
mapping of the iNOS mRNA accessible sites [24]. We chose fluorescein as the
fluorophore and Dabcylplus as the quencher on the complementary strand. We employed a
17-mer DNA strand as the quenching strand. The length of the quenching strand was
determined by two factors: 1. The T m of the duplex under physiological conditions is
around 68 oC (Appendix Figure A 3.1), so it is stable under normal physiological
conditions. 2. The specificity of the probe. We used the Basic Local Alignment Search
Tool (BLAST) to verify the specificity of the PNA probe for iNOS mRNA, and found
that 14 bases are antisense to the nucleoredoxin-like protein 1-like and myosin VA
(Myo5a) mRNA (Table 3.2). Since the quencher strand is a 17-mer, it shouldn’t be
displaced by the non-targeting mRNA. We also knew that the fluorescence of fluorescein
can be influenced by the oligodeoxynucleotide’s primary and secondary structures [25,
26] and in particular that a G base opposite to fluorescein can quench up to 90% of its
fluorescence [27]. To take the advantage of this quenching effect, we designed our PNA
probe to have a C at the 5’ end, to be complementary to a G in the quencher strand at the
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3’ end, which is mismatched to the mRNA sequence. When the PNA probe hybridizes to
the quencher strand, the G base on the 3’ end of the quencher strand enhances the
quenching effect, but when the mRNA displaces the quencher strand, the C at the 5’ end
of the PNA would be opposite to an A base on the mRNA, which will not quench the
fluorescence of the fluorescein. As for the control, we have synthesized a 23-mer PNA
that is antisense to the pLuc 705 cell correct splicing site, which has been shown by
BLAST not to specifically target any mouse mRNAs. The sequences of the probes and
their MALDI results are shown in Table 3.1. For details about the characterizations of
the probes, please refer to Appendix Figures A3.2-A3.6.

Displacement of the quencher probe by complementary DNA
We first tested the strand-displacement reaction by using complementary ODNs,
which have 21 base pairs matched with the PNA probes, whereas the quencher ODNs
only have 17 base pairs matched with the PNA probes. Noting that the PNA has strong
secondary structure at 37 oC, the concentration of the PNA probe was measured by UV
absorbance at 260 nm at 70 oC. As a positive control, the 21-mer ODNs were hybridized
with PNA probes without the quencher strand. From Figure 3.2, we can see that the
quencher ODN can quench 90% of the fluorescence of the PNA480-FAM. By adding the
21-mer cDNA to the quenched probe, 80% of the fluorescence could be recovered. In the
mismatched control group, adding the complementary 21-mer ODN did not recover the
fluorescence of the mismatched probe. All the measurements were done in triplicate and
the average of the fluorescence emission is shown in Figure 3.2 a and b. The reaction
kinetics has also been measured and shown in Figure 3.2 c. The results clearly indicate
that the strand-displacement probe is able to effectively detect the target ODN in solution
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Displacement by in vitro transcribed mRNA
Unlike the model target ODN, in vitro transcribed iNOS mRNA has around 4000
nucleotides (Appendix Figure A3.7), and a complicated secondary structure. Studies in
our lab have shown previously that the iNOS mRNA is accessible to 480 PNA probe, and
the probe has high binding affinity to the in vitro transcribed mRNA. Also, siRNA
knockdown and PNA antisense inhibition experiments verified the accessibility of the
480 site [24]. We first tested whether the iNOS mRNA can displace the quencher strand
in the absence of secondary structure. We mixed the probes together with the mRNA and
heated the mixture to 65 oC for 1 min to disrupt the secondary structure of the mRNA.
When heated, the mRNA will become unfolded and accessible to the probes in the
solution. From Figure 3.3 a and b, It is clear that after 15 min of incubation at 37 oC, the
mRNA can displace the quencher DNA strand, restoring the fluorescence of the matched
probe. For the mismatched probe, heating and cooling the mixture doesn’t increase the
fluorescence, which means the PNA480-FAM probe is specifically targeting the iNOS
mRNA.
We then tested the ability of the probe to detect mRNA at 37 oC. Different
concentrations of mRNA were heated at 65 oC for 1.5 min to unfold them and then
annealed at 37 oC for 15 min in 10 mM Tris buffer to refold. Probes annealed at high
concentration (1 µM) were then added (20 fold dilution) to the mRNA solution in order
to cause minimal volume change of the solution. The fluorescence of the mixture was
monitored as a function of time at 37 oC by the fluorimeter. Figure 3.3 c shows the rate
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of strand-displacement triggered by different concentrations of the mRNA. When the
concentrations of iNOS mRNA increased from 25 nM to 250 nM, which correspond to
0.5 to 5 times the concentration of the probe, both the rates of displacement and the
fluorescence intensity of the mixture increased, consistent with a bimolecular
displacement reaction of the quencher probe. For the mismatched probe, even in the
presence of 100 nM mRNA (2 times of the concentration of the mismatched probe), there
was only a slight increase of fluorescence. However, the strand-displacement rates with
the mRNA are much slower compared to the reactions with the ODN, and the increase of
fluorescence is only around 2.5 fold even when the mRNA is in 5 times excess. This may
be due to the complex secondary structures of the mRNA in solution, which make the
binding sites not fully accessible to the probe. This may also restrict the detection limit
and signal to noise of the probe in cellular experiments.

qRT-PCR and absolute copy numbers of iNOS mRNA inside cells
mRNAs are usually expressed at very low level inside cells, ranging from tens to
thousands of copies per cell [28]. The low copy number of mRNAs can be a problem for
in vivo mRNA imaging because the signal generated will be very low and hard to be
distinguished from background noise. So far, antisense imaging by fluorescently labeled
probes are still limited to relatively abundant transcripts [29]. Expression of iNOS mRNA,
on the other hand, can be stimulated greatly by LPS and γ-IFN, making it a good target
for antisense imaging. To our best knowledge, the actual copy number of iNOS mRNA
inside cells following stimulation has never been reported. To determine the copy
numbers for iNOS mRNA imaging in living cells, we performed a qRT-PCR for
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stimulated and non-stimulated RAW 264.7 cells. The stimulated cells were treated by
LPS/γ-IFN for 6 and 18 h. The in vitro transcribed iNOS mRNA was used to generate a
standard curve, and the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) was used as an internal control to determine the relative increase of iNOS
mRNA. Figure 3.4 shows the average absolute copy numbers per cell in both stimulated
and non-stimulated cells. The copy number for non-stimulated cells was 760 per cell,
after 6 h of treatment, the mRNA copy number was as high as 53,000 per cell, and for
cells stimulated for 18 h it was 76,000 per cell.. Thus the iNOS mRNA increased about
100 fold upon stimulation for 18 h. This large number of transcripts inside stimulated
cells makes the iNOS mRNA an ideal target for antisense imaging. Meanwhile, the ΔΔC T
method using GAPDH control also showed 96 fold increase for the iNOS mRNA after
cells being stimulated for 18 h. This confirms the reliability of the results obtained from
the standard curve method.

Fluorescence in situ hybridization (FISH)
Nucleic acid probes are known to have little cell permeability and require extra
effort to be delivered into the cytoplasm where they can hybridize to the target mRNA
[30]. In order to test the ability of the probes to work independently of the delivery
problem, we examined their ability to detect the iNOS mRNA under fluorescence in situ
hybridization (FISH) conditions. FISH is a 30-year-old technique to detect DNA/RNA in
cells or tissue samples, which are fixed onto glass slides with formaldehyde or methanol.
Samples are then treated with enzymes such as pepsin or detergents such as triton X-100
to destroy the cell membrane to increase their permeability. FISH has been widely
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utilized to image mRNAs and to detect mRNA at the single molecule level [31]. In order
to achieve the best sensitivity, fixation protocols and hybridization buffers have to be
optimized.
Herein we modified a protocol reported by Van de Corput et al [32] and employed
by many researchers to detect mRNA using nucleic acid probes [33, 34]. In FISH
experiments, blocking reagents such as sheared salmon sperm DNA are usually added to
the hybridization buffer to block the nonspecific binding sites. However, we did not use a
blocking reagent because the strand-displacement should only “switch-on” when bound
to the target mRNA. Raw 264.7 cells were fixed and hybridized to the PNA/DNA probes
as described in experimental section. Each sample of cells was scanned in xyz mode, and
the picture of each layer was integrated to determine the fluorescence of the cells. From
Figure 3.5 we can see that cells treated with LPS/γ-IFN show bright green fluorescence
in the cytoplasm of cells. The mismatch probe shows no significant green fluorescence,
indicating that the strand-displacement probe is specific to target mRNA in fixed cells.
The punctate pattern indicates that the iNOS mRNA is dispersed inside cytoplasm. Nonstimulated cells, however, are also fluorescent. This fluorescence may be caused by
fluorescent compounds produced in the fixation process, or from the basal level of iNOS
mRNA in the non-stimulated cells.
Figure 3.5 shows the difference in fluorescence per cell for stimulated and nonstimulated cells using PNA480-FAM probe. The measured difference is 3.6 (±1.8)-fold
which is 25-fold less than expected based on the RT-PCR assay for iNOS expression
under stimulated and non-stimulated conditions. The lower than expected ratio for the
strand-displacement probe may be attributed to both nonspecific binding of the probe and
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the loss of mRNA or probe during the washing steps in the FISH protocol. Although all
of the solutions used were treated with DEPC before use, it is quite possible that some
RNA molecules were not fixed on to the glass surface and were washed off during the
washing steps. The different results between RT-PCR and FISH reflect the pros and cons
of the two methods. FISH can be used to image the mRNA in fixed cells, and show the
location and distribution of the mRNA. However, the high detection limit and low signal
to noise ratio restricts its usefulness for quantitative determination of mRNA copy
number. Real-time PCR on the other hand, has the advantage of quantitatively
determining mRNA copy numbers at very low levels. It is also more reliable and
reproducible, but does not give any information on the spatial location of the mRNA and
is time consuming. These two methods are complementary to each other and may be used
as a combination to study mRNA concentration and distribution in cells.

Strand-displacement imaging of mRNA in living cells
Cellular delivery of nucleic acid probes has always been a major problem for
antisense imaging. One way to deliver PNA into cells is to hybridize the PNA with
negatively charged DNA and complex them with cationic nanoparticles [35]. The
PNA/DNA duplex will associate with nanoparticles via electrostatic interactions and
enter cells via endocytosis. Here we used cationic shell-cross-linked knedel-like (cSCK)
nanoparticles to deliver the PNA/DNA probes into the cells. The cSCK nanoparticles
were developed by our collaborator Professor Karen Wooley, and have been shown to be
able to deliver PNA/DNA and siRNA into cells effectively [36]. We expected that the
probes would remain quenched until the quencher strand on the matched probe was
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displaced by the iNOS mRNA inside cells. Figure 3.6 shows the results of our living
cells imaging following optimization of the concentrations of both the probes and cSCK
nanoparticles. For cells treated with LPS/γ-IFN, and matched probes, there was bright
fluorescence inside the cytoplasm, indicating hybridization of the probes to the mRNA.
For cells not treated with LPS/γ-IFN and cells treated with LPS/γ-IFN but with
mismatched probes, there is little observable fluorescence. Quantification of the
fluorescence indicates that there was a 16.6 (± 7.9)-fold increase in fluorescence of the
cells treated with LPS/γ-IFN than in cells without treatment. Stimulated cells treated with
mismatched probes however, also showed 4.1 (± 2.3)-fold increase in fluorescence
compared to nonstimulated cells. The difference of fluorescence between stimulated and
nonstimulated cells presumably indicated the different expression level of iNOS mRNA
in living cells, however, the LPS/γ-IFN treatment might also affect the delivery efficiency
of cSCK nanoparticles in two groups of cells. Figure 3.6 shows that cells treated with
stimuli are larger than cells not stimulated (about twice in diameter). Such change of
morphology may also be companied with an enhance internalization of the cSCK
nanoparticles, which can bring more probes into cells. To further study the difference of
cSCK uptake in cells under various conditions, fluorescently labeled cSCK nanoparticles
that emit at different wavelengths from the probes need to be used. This dual labeling
strategy will also enable us to study the endosomal trapping and release of the
nanoparticles and PNA probes. Another concern is the degradation of the ODN
quenchers which might cause false positive fluorescent signal. However, it has been
reported that PNA/DNA chimeras are resistant to enzymatic degradations in cell extract
and serum [37]. We believe that hybridizing a DNA to a PNA, and forming complexes
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with cSCK nanoparticles will protect the DNA from enzymatic degradation. Our lab’s
unpublished data have shown that mixing siRNA with cSCK nanoparticles can protect
the siRNA from degradation in serum. The difference of fluorescence between stimulated
cells treated with matched and mismatched probes (around 4-fold) indicates that after 24
hours of incubation, probes can still be protected from total degradation, however, a small
proportion of mismatched probes had opened up, presumably because of probe
degradation or nonspecific binding. Compared to the RT-PCR method, the stranddisplacement activated probes delivered by cSCK nanoparticles can be used to image the
mRNA in living cells, but further optimization will be needed to quantify the iNOS
mRNA, mainly because of the undetermined efficiency of cellular delivery of cSCK
nanoparticles and the stability of the probes in cellular environment.

CONCLUSIONS
We have investigated the use of strand-displacement activated PNA probe to
image iNOS mRNA in solution, in situ, and in living cells. A 23-mer PNA antisense to
the iNOS mRNA was conjugated to a fluorescein, whose fluorescence was quenched by a
Dabcylplus quencher on the 17-mer complementary DNA. We investigated the
displacement reaction in vitro with a short DNA target and with transcribed mRNA and
shown that such displacement probes can be used to image the iNOS mRNA by
fluorescence in situ hybridization. We used qRT-PCR to determine the copy number of
the iNOS mRNA under stimulation and found that after 18 h of stimulation, the mRNA
can increase up to 100 fold and the absolute copy number can reach as high as 75,000
copies per cell. However, the FISH experiment only detected a 3.6 (±1.8)-fold increase in
the iNOS mRNA. This difference may be due to the nonspecific binding of the strand95

displacement probes, as well as the loss of target mRNA during the washing steps in
FISH experiment. We also investigated live cell imaging of iNOS expression using cSCK
nanoparticles as delivery agents. We have showed that the strand-displacement activated
PNA probes delivered by cSCK nanoparticles can be used to image iNOS mRNAs. We
observed a 16.6 (± 7.9)-fold increase in iNOS expression for the stimulated cells.
However, compared to the RT-PCR method, the strand-displacement probes appear to be
less accurate in quantifying the mRNAs inside living cells, possibly because of the lack
of efficient delivery, entrapment in endosomes, and nonspecific binding due to the
complex cellular environment.
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Figure 3.1: Schematic representation of cSCK mediated strand-displacement
activated PNA probes to image mRNA in living cells.
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Figure 3.2: Strand-displacement by DNA target in solution. (a) 0.2 μM 480 PNAFAM (matched) annealed to 0.4 μM 480 quencher DNA. The 480 cDNA were added at
0.1, 0.2, 0.4 and 2 μM concentrations. Positive control: 0.2 μM 480 PNA-FAM annealed
to 0.4 μM 480 cDNA. (b) 0.2 μM pLuc PNA-FAM (mismatched) annealed to 0.4 μM
pLuc quencher DNA. The 480 cDNA was added at 0.4 μM. Positive control: 0.2 μM
pLuc PNA-FAM annealed to 0.4 μM pLuc cDNA. (c) Reaction kinetics. Buffer: 100 mM
Tris-HCl, 5mM MgCl 2, pH=7.10. Excitation wavelength: 488 nm. Temperature: 37 oC.
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Figure 3.3: Strand-displacement by in vitro transcribed iNOS mRNA in solution. (a)
0.2 μM 480 PNA-FAM (matched) annealed to 0.4 μM 480 quencher DNA. The iNOS
mRNA was added at 0.1, 0.2, and 0.4 μM respectively. Positive control: 0.2 μM 480
PNA-FAM annealed to 0.4 μM iNOS mRNA. (b) 0.2 μM pLuc PNA-FAM (mismatched)
annealed to 0.4 μM pLuc quencher DNA. The iNOS mRNA was added at 0.4 μM. Buffer
solution: 0.1 M KCl, 5 mM MgCl 2 , 10 mM Na-Hepes. pH=7.11. Solutions were heated at
65 oC for 1 min and incubated at 37 oC for 15 min.
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Figure 3.3: Strand-displacement by in vitro transcribed iNOS mRNA in solution. (c)
Reaction kinetics. 0.05 μM 480 PNA-FAM (matched) or pLuc PNA-FAM (mismatched)
was annealed to 0.1 μM 480 quencher DNA or pLuc quencher DNA. The iNOS mRNA
was added at 0.025, 0.5, 0.1 and 0.25 μM for different samples. Buffer: 10 mM Tris-HCl,
pH=7.15. Excitation wavelength: 488 nm, emission at 525 nm. Temperature: 37 oC. All
the curves were normalized and zeroed at their starting fluorescence.
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b.
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c.

Figure 3.4: RT-PCR to determine the absolute copy numbers of iNOS mRNA in
RAW 264.7 cells. Cells were treated with LPS and γ-IFN for 6 h or 18 h. Untreated cells
were incubated under the same condition without stimuli. (a). Standard curve generated
from known amount of in vitro transcribed mRNA. (b). Absolute copy number of iNOS
mRNA in cells obtained from the standard curve. (c). Comparison of standard curve
method and ΔΔC T method to determine the relative increase of iNOS mRNA in cells.
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Figure 3.5: Fluorescence in situ hybridization (FISH) images of iNOS mRNA
in RAW 264.7 cells and the quantitative analysis of fluorescence in selected
regions of interests (ROIs).
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Figure 3.6: Confocal fluorescent images of iNOS mRNA in RAW 264.7 cells
and the quantitative analysis of fluorescence in selected regions of interests
(ROIs). For each sample, 0.4 μM PNA probe was delivered with 9.7 μg/mL cSCK
nanoparticles. N/P=8:1. Green: FAM signal. Blue: Hoechst nuclear stain.
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Table 3.1: Sequence design, dye structures and MALDI results of the probes
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Sequence name
Mus musculus
nitric oxide
synthase 2
(iNOS) mRNA

Mus musculus
nucleoredoxinlike protein
1-like mRNA
Mus musculus
myosin VA
(Myo5a), mRNA

Number of
matched
base pairs

Sequence complementary to 480 PNA-FAM probe

PNA

2

mRNA

494

PNA

10

mRNA

27

PNA

3

mRNA

4645

CAAGTGAAATCCGATGTGGCCT
||||||||||||||||||||||
CAAGTGAAATCCGATGTGGCCT

ATCCGATGTGGCCT
||||||||||||||
ATCCGATGTGGCCT

23

AAGTGAAATCCGAT
||||||||||||||
AAGTGAAATCCGAT

16

23
22
473

14

4632

Table 3.2: BLAST results for 480 PNA-FAM probe
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14

14

Appendix
1.2

FL intensity

1
0.8
0.6

Ramp1
Ramp2

0.4
0.2
oC

0
25

1.2

35

45

55

65

75

85

FL
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oC

0
25
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Figure A 3.1: Tm measurement of 480 PNA-FAM/DNA-Dabcylplus (top)
and pLuc PNA-FAM/DNA-Dabcylplus (bottom). 0.2 μM of probes were
annealed in 100 mM Tris, 5mM MgCl2 buffer. Fluorescence intensity of the
probes was measured at excitation at 488 nm and emission at 525 nm.
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Figure A 3.2: HPLC trace and MALDI-TOF mass spectrum of 480 PNA-FAM.
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Figure A 3.3: HPLC trace and MALDI-TOF mass spectrum of pLuc PNA-FAM.
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8029

Figure A 3.4: Separation of DNA-Dabcylplus by PAGE. Left arrow: 480 DNADabcylplus. Right arrow: pLuc DNA-Dabcylplus.
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Figure A 3.5: Uv-Vis spectra of 480 DNA-Dabcylplus (top) and pLuc DNADabcylplus (bottom).
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Figure A 3.6: MALDI-TOF spectra of 480 DNA-Dabcylplus (top) and pLuc DNADabcylplus (bottom).
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7025.0

Figure A 3.7: Gel electrophoresis image of iNOS plasmid and mRNA on
1% agarose gel. Stained with ethidium bromide. Lane 1.iNOS plasmid after
enzyme digestion. 2. iNOS plasmid before enzyme digestion. 3. DNA
ladder. 4. RNA ladder. 5. In vitro transcribed iNOS mRNA.
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Chapter Four
FRET PNA probes for imaging inducible nitric oxide synthase (iNOS)
mRNA in living cells
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ABSTRACT
Förster resonance energy transfer (FRET) has been widely used to study the
interactions between macromolecules in biological systems, such as proteins and nucleic
acids. One application of the FRET is to detect mRNAs using fluorescently labeled
nucleic acid probes. In this study, we explored the FRET technology to image iNOS
mRNA, whose transcription is induced upon environmental stimulation. Peptide nucleic
acids (PNA) bearing donor dyes (Fluorescein or Cy3) or receptor dye (Cy5) were
synthesized and were designed to target adjacent sites on the iNOS mRNA. We were able
to detect the FRET signal of Cy5 dye at 670 nm by exciting the donor dye at 488 nm
(Fluorescein) or 535 nm (Cy3) when the FRET probes bind to the complementary DNA
in solution. FRET pairs with FAM and Cy5 were chosen to detect in vitro transcribed
iNOS mRNA. The PNA FRET probes were first annealed to partially complementary
oligodeoxynucleotides (ODNs) so that they would bind to cationic cSCK nanoparticles
which delivered the probes into RAW 264.7 cells. We were able to show that these PNA
FRET probes could be used to image iNOS mRNA in living RAW 264.7 cells.
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INTRODUCTION
Förster resonance energy transfer (FRET) is an energy transfer mechanism that can
take place between nearby fluorescent molecules [1]. The energy transfer takes place
through nonradiative dipole-dipole coupling interaction, in which the energy of one
molecule (the donor) at electronic excited state is transferred to the other molecule (the
acceptor), resulting in emission of the acceptor. One of the most important factors that
determine the efficiency of FRET is the distance between the donor and the acceptor. The
effective range for FRET is from 10 to 100 Å [2]. Therefore, researchers often use FRET
to study the interactions between molecules, such as nucleic acid hybridization [3],
protein-protein interactions [4, 5], and protein-nucleic acid interactions [6, 7]. One
application of FRET is to image mRNA in living cells using fluorescently labeled nucleic
acid probes. Compared with other methods that detect mRNA, such as RT-PCR [8],
which requires the lysis of the cells or tissue, nucleic acid hybridization probes can be
used to monitor the mRNA in vivo in real time [9, 10].
A typical FRET design for nucleic acid probes is the “binary probes”, which
utilizes two single strand nucleic acid probes bearing two different dyes. Upon
hybridizing to a target at neighboring sites, FRET can occur between the donor and the
acceptor dye [11]. This design depends on the successful hybridization of the probes, and
can eliminate signal from unbound probes because the excitation wavelength of the donor
is usually chosen so that it does not overlap that of the acceptor.
Because traditional DNA probes are susceptible to enzymatic degradation and can
trigger RNase H degradation of the mRNA target, many DNA mimics have been
developed that have higher biological stability and won’t trigger RNase H activity.
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Peptide Nucleic Acid (PNA) is a DNA analogue with N-aminoethylglycine-based
polyamide backbone. It can hybridize to DNA or mRNA with high specificity and
binding affinity [12-14]. PNA probes are more resistant to nuclease degradation and will
not induce RNase H activity upon hybridizing to the mRNA [15]. Researchers have
successfully used PNA FRET probes to investigate mRNA splicing both in solution and
in fixed cells [16, 17], by targeting two exons to be spliced with a donor and acceptor
probe. In the pre-mRNA, the exons are separated by an intron which prevents FRET from
occurring, but after splicing, FRET will occur because the two exons become linked to
each together.
FRET probes have also been used to image mRNA in living cells, although the
intracellular delivery of the probes remains to be one of the biggest challenges for mRNA
imaging in living cells. For example, Tsuji and coworkers have used labeled DNA FRET
pairs to visualize specific mRNA inside living cells by directly injecting the probes into
cells [18, 19]. Other methods for intracellular delivery of FRET probes include
electroporation [20] and reversible pore-forming agents such as Streptolysin-O (SLO) [21,
22]. Although these methods have been shown to enable the delivery of nucleic acid
probes into cytoplasm, they are time consuming, cause damage to the cells, and cannot be
used for in vivo studies. Another method for delivering nucleic acid probes is to use
synthetic agents such as nanoparticles [23, 24]. These particles are usually positively
charged so that they can associate with cell membranes and enter cells via endocytosis.
Nucleic acid probes can associate with cationic nanoparticles via electrostatic interactions,
or via covalent bonds. Because the PNA probes are uncharged, they have to be first
hybridized to a negatively charged ODN to form complexes with cationic lipids or
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nanoparticles [25]. The advantage of using nanoparticles for delivery is that they can be
modified with other functional groups, such as polyethylene glycol (PEG) to increase
their retention time in the blood stream, or specific targeting ligands to achieve high
efficiency for in vivo delivery [24]. Recently, the Wooley group has developed a cationic
shell-cross-linked (cSCK) nanoparticle. Through collaborative work between our two
labs, Huafeng Fang and Ke Zhang have shown that cSCK nanoparticles can effectively
deliver DNA plasmid and PNA/DNA hybrids into HeLa and pLuc 705 cells. They have
also conjugated the PNAs onto cSCK nanoparticles via disulfide bonds and shown that
the disulfide bond can be cleaved inside cells to release the PNA [26-28].
In this chapter, we will report on the design and synthesis of peptide nucleic acid
(PNA) FRET probes and their use for detecting iNOS mRNA, whose transcription is upregulated in inflammation or by environmental stimuli such as lipopolysaccharide (LPS)
or γ-interferon (γ-IFN) [29]. We will demonstrate the ability of the FRET probes to detect
a complementary DNA target and in vitro transcribed iNOS mRNA. We will also
demonstrate the ability of cSCK nanoparticles to deliver the PNA probes annealed to
partially complementary ODNs into living cells (Figure 4.1). We will show that this
nanoparticle-based FRET probe system can be used to image iNOS mRNA in living
RAW 264.7 cells.
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EXPERIMENTAL PROCEDURES
Materials:
Anhydrous N,N-dimethylformamide (DMF), diisopropylethylamine (DIPEA),
trifluoroacetic acid (TFA), meta-cresol, dichloromethane (DCM), N-methylpyrrolidone
(NMP) were purchased from Sigma-Aldrich (St Louis, MO). PNA monomers were
purchased from PolyOrg, Inc (Leominster, MA). Fmoc protected amino acids were
purchased from EMD chemicals (Gibbstown, NJ). 2-(1H-7-Azabenzotriazol-1-yl)1,1,3,3-tetramethyl uronium hexafluorophosphate (HATU) was purchased from
GenScript (Piscataway, NJ). (5,6)-fluorescein-N-succinimidyl ester (FAM-NHS ester)
were purchased from Sigma-Aldrich (St Louis, MO). Cy3-N-hydroxysuccinimidyl ester
(Cy3-NHS ester) was purchased from Lumiprobe, LLC (Hallandale Beach, FL). Cy5-Nhydroxysuccinimidyl ester (Cy5-NHS ester) was synthesized and provided by Jillian
Smith from our lab. Fmoc-PAL-PEG-PS resin for the solid phase PNA synthesis was
purchased from Applied Biosystems (Carlsbad, CA). The PNAs were synthesized by
solid-phase Fmoc chemistry on an Expedite 8909 DNA/PNA synthesizer at 2 µmol scale.
All the DNA oligonucleotides were purchased from Integrated DNA technologies
(Coralville, IA). The crude PNA probes were purified by reversed phase highperformance liquid chromatography (HPLC) on a Beckman Gold System with a UV
array detector and a Varian Microsorb-MV column (C-18, 5µm, 300 Å pore size,
4.6×250 mm internal diameter and length). Running buffer A contains 0.1% TFA in
water, and B contains 0.1% TFA in acetonitrile. The purified probes were characterized
by MALDI-TOF mass spectrometry on an Applied Biosystems 4700 MALDI-TOF mass
spectrometer. The concentration of the DNAs was determined from the absorbance at 260
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nm on a Bausch and Lomb Spectronic 1001 spectrophotometer. PNA concentrations were
determined from the absorbance at 260 nm at 70 oC.
Synthesis of the FRET probes
PNAs were synthesized on the Expedite 8909 PNA synthesizer. Fmoc-Lys (Mtt)OH was attached to the N terminus on the donor PNA and to the C terminus on the
acceptor PNA. After the PNA synthesis was completed, the column was taken out from
the synthesizer and the N-terminal NH 2 of the PNA was capped with capping solution (5%
acetic anhydride, 6% 2,6-lutidine in DMF) using double syringes for 10 min. Then the
Mtt group on the lysine was then removed by washing the column with 1% TFA in DCM
until the yellow color of the deprotection mixture faded away. The column was then
washed twice by DCM followed by 5% DIPEA in DCM for 5 min. The column was dried
by nitrogen gas and infused overnight with FAM-NHS ester (4 μmol, 2 eq), Cy3-NHS (4
μmol, 2 eq) or Cy5-NHS (4 μmol, 2 eq) ester in dry DMSO with DIPEA (4 μmol, 2 eq).
The excess dyes were then washed off column by DMF and DCM. The dried resin was
taken out from column and cleaved by cleavage cocktail (20% m-cresol in TFA, 250 μL)
for 2 to 4 h. Crude PNA products were precipitated by cold ether, dried, dissolved in 0.1%
TFA water and filtered through an Xpertek syringe filter (13 mm, 0.45 µm) before HPLC
purification. The purified PNA-FRET probes were dried in a SC110A Thermo Savant
speed vacuum system and re-dissolved in de-ionized water to make stock solutions. The
concentration of the solutions was determined from the absorbance at 260 nm at 70 oC.
All probes were characterized by MALDI-TOF mass spectrometry.
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FRET studies with DNA templates in solution
FRET probes were hybridized to the DNA template in 100 mM Tris 5 mM MgCl 2
buffer. The concentrations of PNA1-FAM or PNA2-FAM and the DNA target were 0.5
µM. PNA3-Cy5 was added at different concentrations (0 µM, 0.3 µM and 0.6 µM). For
negative controls, one sample contained 0.6 µM PNA3-Cy5 and 0.6 µM DNA template
and others included 0.5 μM PNA1-FAM or PNA2-FAM mixed with an excess amount of
PNA3-Cy5 (2.4 μM) without the DNA template. The probes and targets were mixed in
solution and excited at 488 nm. To compare FAM and Cy3 as donors, 0.5 µM PNA2FAM or PNA2-Cy3 was mixed with 0.5 µM PNA3-Cy5 and 0.5 µM target DNA. All the
solutions were heated at 95 oC for 2 min and allowed to anneal at 37 oC. Each sample
solution was excited at the donors’ absorption maximum (488 nm for FAM or 535 nm for
Cy3) and the fluorescence spectra were collected on a Varian Eclipse Fluorimeter.

FRET probes to detect in vitro transcribed iNOS mRNA
PCMV-SPORT6 vector containing the iNOS mRNA gene was purchased from
American Type Culture Collection (ATCC, Manassas, VA). E. coli containing the vector
was inoculated in LB media at 37 oC for 18 h. The plasmid was extracted from the E. coli
by using HiPure Plasmid Maxprep kit (Invitrogen) following the manufacturer’s protocol.
The plasmid was then digested by restriction enzyme Xbal (Promega, WA). The resulting
linear plasmid was characterized by electrophoresis on a 1% agarose gel in TAE buffer.
The linearized plasmid was then transcribed with MEGAtranscript® SP6 (Ambion) kit to
produce an mRNA of around 3.9 K bases that was verified by gel electrophoresis on a 1%
agarose gel using DEPC treated TAE buffer. The mRNA was quantified by its
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absorbance at 260 nM and its estimated molecular weight of 1284 µg/nmol. The mRNA
was dissolved in OPTI-MEM® solution to make a 0.2 µM solution, together with equal
molar amounts of PNA2-FAM or PNA3-Cy5 or both. Samples were incubated at 37 oC
for 30 min. The fluorescence spectrum of each sample was collected at excitation
wavelength of 488 nm. For a negative control, 0.2 µM PNA2-FAM and a mismatched
PNA-Cy5 sequence (pLuc sequence that targeting the splicing correction site of pLuc 705
cells) were mixed with 0.2 µM iNOS mRNA. The fluorescence of the control sample was
taken under the same conditions as other samples. For the positive control, equal molar
FRET probes and mRNA were mixed and heated at 65 oC for 2 min before incubation at
37 oC for 30 min.
To test the strand-displacement of the PNA/DNA probes delivered into live cells,
the 15mer PNA FRET probes and control probes were hybridized to 13mer ODNs, which
have 9 bases complementary to the PNA probes with a 4 base overhang. The mixed
probes (0.2 μM) were then incubated with 0.2 µM iNOS mRNA in OPTI-MEM® solution
for 30 min at 37 oC. Fluorescence spectra were taken with excitation at 488 nm.

FRET imaging of iNOS mRNA in living cells
Mouse macrophage RAW 264.7 cells were seeded on 14 mm glass-bottom dish
(MatTek, MA) at 1 × 105 cells/well and incubated overnight until reaching about 70%
confluence. Some samples were then treated with 1 µg/mL LPS and 300 ng/mL γ-IFN for
18 h. Cells were then treated with cSCK/PNA-DNA for 6 h or 24 h respectively.
For cells treated for 6 h, PNA2-FAM and PNA3-Cy5 were first annealed to their
complementary ODNs, and mixed with cSCK at an N/P ratio of 10:1 in Opti-MEM®
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medium. The mixture was incubated at room temperature for 20 min to let the cSCK fully
complex with the PNA/DNA duplexes electrostatically. Then the solution containing the
donor/acceptor/cSCK was mixed with DMEM medium containing 10% FBS and added
to the cells. The final volume was 150 µL and the final concentration of the probes and
the cSCK were 0.5 µM and 18.1 µg/mL respectively. LPS (1 µg/mL) and γ-IFN (0.3
µg/mL) were added to the delivery media to keep inducing the iNOS mRNA. Samples
were incubated at 37 oC in a wet chamber with 5% CO 2 for 6 h.
For cells treated for 24 h, PNA2-FAM, PNA3-Cy5 or pLuc-Cy5 was first annealed
to their complementary ODNs separately in 25 µL Opti-MEM®. For each solution, cSCK
nanoparticles were added at the N/P ratio of 8:1 and the mixture was incubated at room
temperature for 20 min. Solutions containing donor/cSCK and acceptor/cSCK (or
mismatched probes) were then mixed together with 100 µL DMEM medium containing
10% FBS to make a final volume of 150 µL and were added to the cells. The final
concentration of each probe was 0.5 µM, and the cSCK concentration was 14.5 µg/ml.
For stimulated samples, LPS (1 µg/ml) and γ-IFN (0.3 µg/ml) were added to the media to
keep inducing the iNOS mRNA. Cells were incubated at 37 oC in a wet chamber with 5%
CO 2 for 24 h and then washed and observed by confocal microscope. Cells incubated
with probes for 6 h were observed with a Nikon A1 confocal microscope and cells
incubated with probes for 24 h were observed with an Olympus Fluoview FV1000
confocal microscope with a lambda scan function. The FRET spectra of the cells treated
with the probes for 24 h were collected by performing the lambda scan. Images were
analyzed using the image J software.
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RESULTS AND DISCUSSION
Design and synthesis of the PNA FRET probes
PNAs were selected to construct the FRET probes for their high binding affinity to
RNAs and resistance to enzymatic degradation [30]. A former lab member, Bereket
Oquare, had previously shown that FRET pairs based on fluorescein and Cy5 could be
used to detect a DNA sequence in solution [31] and so we chose this pair for initial
studies. The sequences of the PNAs for our study were chosen to target iNOS mRNA
from position 236 to 272 (Table 4.1). This site is one of the accessible sites according to
our lab’s published results [32]. A binding affinity assay conducted by our lab member
Yuefei Shen showed that two PNA probes targeting this sites (probes 240 and 261) have
high binding affinity to the iNOS mRNA with K d s of 101 and 68 pM respectively (Table
4.2). This is also a purine rich region, which means the antisense PNAs are pyrimidine
rich and won’t have complex secondary structures and solubility problems.
One key consideration in designing the FRET probes was the length. Probes need
to be long enough to be specific for the target mRNA, but not so long that they will bind
with mismatched sequences under physiological conditions. Because of their higher
affinity to the target mRNA than the DNA probes, PNA probes are usually shorter, with
around 13 to 15 base pairs [16, 17]. The PNAs used in this study are 15-mers and the
specificity of the probes was verified by searching through Basic Local Alignment Search
Tool (BLAST) data base. While PNAs 2 is highly specific for iNOS mRNA, PNA 1 and
PNA3 may also target other mRNAs with 14 or more 15 base pairs. However, since the
FRET signal can only be detected upon successful hybridization of the two probes to
adjacent sites on the target mRNA, even if one probe can bind non-specifically to other
sequences, it won’t cause significant background signal as long as the other probe does
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not bind close to it. The PNAs were modified with a lysine group on their 3’ or 5’ end,
and the ε-amino group of the lysine was used to conjugate the donor and acceptor dyes.
Table 4.1 shows the sequences of each probes and their observed mass by MALDI mass
spectrometry. The detailed characterization of the probes were shown in the appendix
Figures A 4.1-A4.5.

FRET study with DNA template in solution
In order to find an optimal FRET probe pair for imaging iNOS mRNA, we
synthesized PNAs separated by 2 or 6 bases when hybridized to the target. We also tested
different fluorescent dyes to achieve the optimal FRET efficiency and the lowest
background. Figure 4.2 A and B compare the FRET efficiency of different pairs of
probes with the same template ODN. When the amount of acceptor probe increased, the
FRET signal also increased. However, mixing the acceptor PNA alone with the DNA
template did not result in any FRET signal. This indicates that the emission of Cy5 can
only come from FRET and not from direct excitation of the acceptor with 488 nm light.
As a general trend, sequences 2 and 3 yield higher FRET signals than sequences 1 and 3.
This may be because sequences 2 and 3, which are 2 bases apart, are closer to each other
than sequences 1 and 3, which are 6 bases apart. Another reason could be that the FAM
on PNA1 is next to a C base, which would be paired to a G base on the DNA template
that might quench the fluorescence of the FAM, thereby weakening the FRET signal of
Cy5 [33].
We also compared the FRET observed from FAM with the FRET from Cy3 using
Cy5 as the acceptor (Figure 4.3 A and B). While the excitation maximum for FAM is
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488 nm, it is 535 nm for Cy3. Although Cy3 and Cy5 pairs show a higher FRET
efficiency and stronger signal, the emission spectrum of Cy3 also overlaps slightly with
Cy5’s emission spectrum, which results in a background signal. On the other hand, the
emission spectrum of FAM doesn’t show any overlap with the emission of Cy5. Based on
these results, we chose PNA2-FAM as the donor and PNA3-Cy5 as the acceptor for our
in vivo experiments. Similar DNA-based FRET pairs have been utilized by Tsuji et al [19]
to image RNA in living cells.

FRET study with in vitro transcribed mRNA in solution
In order to see if our FRET probes would be suitable for imaging iNOS mRNA in
vivo, we first tested their ability to detect in vitro transcribed iNOS mRNA in solution.
After mixing PNA2-FAM and PNA3-Cy5 with equal amounts of iNOS mRNA at 0.2 µM
in Opti-MEM® medium a significant FRET signal was detected at 670 nm. However,
when the donor sequence and a mismatched Cy5 bearing sequence were mixed with the
mRNA, there was no observable FRET signal (Figure 4.4 A). This means that FRET
occurred because of the successful hybridization of the probes with the iNOS mRNA.
Heating the mRNA to 65 oC, further increased the FRET signal presumably because the
mRNA unfolded making the target site more accessible. It is worthwhile to note that
mRNA may have different secondary structures under different conditions and that the
mRNA may adopt a different structure in living cells.
To deliver the probes inside the cells, the PNA probes would have to be annealed
to complementary DNAs so that they can be electrostatically bound to the cSCK
nanoparticles. When the nanoparticles deliver probes into cytoplasm, the DNA strand
will be displaced by the iNOS mRNA. We have utilized such a strand-displacement
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strategy in the previous chapter. We therefore first tested the strand-displacement of such
PNA-DNA hybrids by iNOS mRNA in solution. Figure 4.4 B shows that the iNOS
mRNA can displace the short DNAs on the PNA probe and a FRET signal can be
detected in solution. This observation demonstrates the viability of the system for
imaging in living cells.

FRET imaging of iNOS mRNA in living cells
For live cell imaging studies the FRET PNA probes were first hybridized to
partially complementary ODNs so that they could be delivered into living RAW 264.7
cells via cSCK nanoparticles. cSCK nanoparticles are positively charged nanoparticles
that can bind PNA/DNA duplexes via electrostatic forces. The ability of the PNA/DNA
duplexes to bind cSCKs depends on the N/P ratio which refers to the number of amines
on the particle (number of positive charges) over the number of phosphates (negative
charges) on the DNA backbone. Gel retardation assay conducted by our lab member
Yuefei Shen (Appendix Figure A 4.6) has shown that for the cSCK to form complexes
with PNA/DNA duplexes and thereby retard the migration of the duplexes on
polyacrylamide gel electrophoresis (PAGE), the N/P ratio needs to be 4 or higher. As N
increases, more PNA/DNA duplex will associate with cSCK nanoparticles, which will be
taken up by the cells via endocytosis. It is hypothesized that once trapped in the
endosomes, the cSCK will help release the probes via the “proton sponge” effect, in
which the amino groups will buffer against the increase of protons as the endosomes
acidify, bring more protons and counter ions inside the endosomes. The accumulation of
counter ions will increase the osmotic pressure that leads to the disruption of the
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endosomes [28]. However, cSCKs are also toxic to cells at higher concentrations [28].
Therefore, the concentrations of the cSCK and probes need to be optimized to most
efficiently deliver the probes into the cells with minimum cytotoxicity. In our study, we
have used an N/P ratio of 10 for cells treated for 6 h and decreased the N/P ratio to 8 for
cells treated for 24 h while maintaining the same probe concentration of 0.5 µM to
minimize the toxicity at longer times. Cells were treated with LPS and γ-IFN for 18 h to
induce iNOS mRNA expression and then incubated with cSCK/PNA/DNA polyplexes.
LPS and γ-IFN were added again during the cSCK transfection period to keep the
expression level of the mRNA high. We have found that after 6 h, most of the probes
were associated with cell membranes, and did not penetrate deeply into the cytoplasm
(Figure 4.5). There was also no observable FRET signal detected, consistent with most
of the probes being trapped in the membrane or endosomes and not reaching the mRNA
in the cytoplasm. After 24 h of incubation, however, the probes appeared to be inside the
cytoplasm, and the fluorescence was more diffuse, indicating the release of the probes
from endosomes and hybridization to the iNOS mRNA. The confocal images in Figure
4.6A shows that when excited at 488 nm, cells treated with FRET probes emitted
detectable FRET signal at 650-700 nm. For the non-stimulated cells (Figure 4.6 B) and
stimulated cells treated with mismatch Cy5 probes (Figure 4.6 C), there was very little
FRET signal detected.
To better quantify the FRET signal, a wavelength scan was performed to show the
FRET spectrum of different regions of interest (ROI). Cells were excited at 488 nm and
fluorescence images of the cells were collected at 10 nm intervals. The spectra of ROIs
clearly show that antisense FRET PNA probes were giving strong FRET signals inside

133

the cells. Changing the acceptor probe to a control sequence showed no FRET signal in
the stimulated cells, indicating that the FRET signal was produced by hybridization of
FRET probes to the iNOS mRNA, rather than through proximity effects in the polyplexes
with the cSCK, which might bring the two probes close to each other. For the nonstimulated cells, the FRET signal could also be detected, but was significantly weaker
than the FRET signal in the stimulated cells. The difference in FRET signal intensity for
selected regions of interests (ROI) of stimulated and non-stimulated cells was 3.8 (± 0.9)fold (Figure 4.7).

CONCLUSION
We have synthesized fluorescently labeled PNA FRET probes that can hybridize to
adjacent positions on iNOS mRNA. We have optimized targeting positions of the probes
and fluorescent molecule pairs for this study. We have shown that the 15mer PNA
labeled with FAM or Cy3 (donor) and the PNA labeled with Cy5 (acceptor) can
hybridize to the target DNA and mRNA in vitro and produce FRET signals that can be
detected by a fluorimeter. We then showed that these probes could be delivered into
living cells by hybridizing them with partially complementary DNAs and complexing
them with cSCK nanoparticles and that After 24 hours of incubation, FRET signals could
be observed in iNOS stimulated living cells. Control probes showed no FRET signal and
non-stimulated RAW cells showed a weaker FRET signal, which confirmed that the
FRET image observed in stimulated living cells was due to hybridization of the probes to
the iNOS mRNA. By using the FAM and Cy5 FRET pairs, we were able to avoid
overlapping of the emission spectra of the two dyes, though perhaps at the expense of a
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lower FRET efficiency. The Cy3 and Cy5 FRET pairs, while having much higher FRET
efficiency, also have slightly overlapping emission. Therefore, unbound Cy3 probes, if in
large excess, could interfere with detection of the FRET signal from the bound probes.
Nonetheless, a design that combines the strand-displacement probes and FRET probes
may solve this problem. Instead of using unmodified DNAs to hybridize with the PNA,
DNA bearing fluorescent quenchers could be used to quench the signals of fluorophores.
Only when both quencher strands are displaced by the iNOS mRNA will the FRET signal
be detected. This design will be more likely to give higher signal/noise ratio in living
cells by having lower background noise of the unbound probes. It will also eliminate the
possible unwanted FRET signal from the interaction of cSCK associating with two FRET
probes.

135

Figure 4.1: Schematic representation of FRET PNA probes for imaging iNOS
mRNA in living cells.
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Figure 4.2: FRET probes hybridizing with DNA template. A. PNA1-FAM and PNA3Cy5 probes. B. PNA2-FAM and PNA3-Cy5 probes. PNA1-FAM and PNA2-FAM
concentration: 0.5 μM. DNA template concentration: 0.6 μM. PNA3-Cy5 was added in
different amount (0, 0.3, 0.6 μM). For a negative control, 0.5 μM PNA1-FAM or PNA2FAM was mixed with excessive amount of PNA3-Cy5 (2.4 μM) without DNA template.
Buffer: 100 mM Tris 5 mM MgCl 2 , pH=7.1. Excitation wavelength: 488 nm.
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Figure 4.3: Comparison of FAM and Cy3 as FRET donors. 0.5 μM PNA2-FAM (A.)
or PNA2-Cy3 (B.) was mixed with 0.5 μM PNA3-Cy3 and DNA template in buffer
containing 100 mM Tris 5 mM MgCl 2 . For the positive control, no PNA3-Cy5 was added.
Excitation wavelength: 488 nm for FAM and 535 nm for Cy3.
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Figure 4.4: FRET PNA probes to detect in vitro transcribed iNOS mRNA. A. 0.2 µM
PNA2-FAM and PNA3-Cy5 or pLuc-Cy5 (mismatch) were incubated with 0.2 µM in
vitro transcribed iNOS mRNA at 37 oC for 30 min. Positive control including 0.2 µM
PNA2-FAM, PNA3-Cy5 and iNOS mRNA was heated at 65 oC for 1 min to unfold the
mRNA before incubation at 37 oC for 30 min. B. 0.2 µM PNA2-FAM and PNA3-Cy5
were annealed to their partially complementary ODNs and incubated with the iNOS
mRNA at 37 oC for 30 min. Controls are 0.2 µM PNA2-FAM or PNA3-Cy5 incubated
with the iNOS mRNA under the same conditions. Buffer solution: Opti-MEM® medium.
Excitation wavelength 488 nm.
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Figure 4.5: Confocal images of stimulated RAW 264.7 cells treated with cSCK and
FRET probes for 6 h. Cells were treated with 0.5 µM PNA2-FAM /DNA2, 0.5 µM
PNA3-FAM /DNA3 and 18.3 μg/ml cSCK. N/P ratio is 10:1. Cells were incubated for 6
hours and stained with Hoechst 33258 nuclear staining dye for 1 h. Green: excitation at
488 nm, FAM signal. Red: excitation at 633 nm, Cy5 signal. Blue: excitation at 405 nm,
hoechst signal.
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A: Stimulated cells, FRET probes.
Excitation: Donor
Emission: Donor

Excitation: Donor
Emission: Acceptor

B: Nonstimulated cells, FRET probes.
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Excitation: Acceptor
Emission: Acceptor

C: Stimulated cells, mismatched acceptor probe.

Figure 4.6: Confocal images of cells treated with cSCK and FRET probes for 24 h.
PNA2-FAM and PNA3-FAM or pLuc-Cy5 were annealed to the partially complementary
ODNs and mixed with cSCK nanoparticles. The concentration for each probe was
0.5 µM and the cSCK concentration was 14.5 μg/ml. N/P: 8. A. Stimulated RAW 264.7
cells treated with PNA2-FAM and PNA3-Cy5. B. Nonstimulated RAW 264.7 cells
treated with PNA2-FAM and PNA3-Cy5. C. Stimulated RAW 264.7 cells treated with
PNA2-FAM and pLuc -Cy5.
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Folds of increase

Figure 4.7: Average FRET intensity for cells in selected ROI in Figure 4.6A and B.
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Table 4.1: Sequences and MALDI results of the probes.

144

Table 4.2: Binding affinity of PNAs for iNOS mRNA (Yuefei Shen).
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Figure A 4.1: HPLC trace and MALDI-TOF mass spectrum of PNA1-FAM.
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Figure A 4.2: HPLC trace and MALDI-TOF mass spectrum of PNA2-FAM.

147

6023.0

3000

Det 168-260 nm
051311 CY3 PNA seq2.dat

Area Percent

mAU

2000

1000

0

2

4

6

14
12
Minutes

10

8

16

18

20

22

24

4585.56

100

2648.2

90

80

70

% Intensity

60

50

4606.51
4316.72

40
4331.62
4569.51

30

4065.19

20

10

0
2499

3304

4109

4914

5719

Mass (m/z)

Figure A 4.3: HPLC trace and MALDI-TOF mass spectrum of PNA2-Cy3.
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Figure A 4.5: HPLC trace and MALDI-TOF mass spectrum of pLuc-Cy5.
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6022.0

Figure A 4.6: Gel retardation assay of PNA/DNA hybrid mixed with cSCK
nanoparticles (Yuefei Shen). 0.5 uM of PNA/DNA (2:1) hybrids mixed
with serial amounts of cSCK with different N/P ratio. Incubated in PBS for
30 min. Native PAGE gel.
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Chapter Five
Summary, conclusion and future studies
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Methods for detecting and imaging gene expression in vivo would be of great use
for fundamental research and biomedical applications. To image mRNA in vivo is a
challenging task, due to the low abundance of mRNAs [1], their secondary structure [2]
and difficulty in getting the required nucleic acid probes inside cells. The overall goal of
this dissertation was to develop methods and techniques for detecting and imaging
mRNA both in vitro and in living cells that could ultimately be used in vivo. We have
explored three approaches to achieve this goal: (1) aptamer tagged transgenic mRNA
imaging; (2) strand-displacement activated PNA probes; and (3) adjacent PNA FRET
probes.
We first investigated the use of malachite green (MG) to image MG binding
aptamer tagged transgenes in living cells. Two major advantages of using MG for
detecting transgene RNA are that the MG binding aptamer can increase the fluorescence
of MG up to 2000 fold [3], and that (2) the transgene can be engineered to contain
multiple repeats of the aptamer, thereby enhancing the fluorescence signal. We
investigated the ability of using the MG aptamer system to image and detect transgenic
mRNA in living cells utilizing constructs developed by Dr. Huafeng Fang. These
constructs consisted of a β-adrenergic receptor gene fused to green fluorescent protein
(GFP) gene to which was appended multiple repeats of the Malachite binding aptamer.
This vector was successfully transfected into MDCK cells, as verified from fluorescence
from the GFP protein. We were then able to show that the transgene mRNA could be
successfully detected in the presence of MG in solution and in total RNA extracted from
transfected cells. We have shown by confocal microscopy that transfected cells
expressing GFP could also be imaged by fluorescence from the MG molecules. Although
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MG has been reported to show around 2000 times increase in fluorescence upon binding
to the aptamer in vitro, we only observed 22-fold increase in fluorescence for MG upon
binding to the aptamer in cellular RNA extracts, and only 1.3-fold increase in living cells.
The weaker than expected signal could be attributed to overloading of the cells with MG
or to non-specific binding of MG to other cellular components. It is also possible that
there were very few aptamer tagged mRNAs being expressed which were outnumbered
by excess amounts of MG molecules inside cells, We did find, however, that the signal to
noise ratio increased with incubation time after MG was removed from the media,
presumably because the unbound MG molecules could exit cells via free diffusion.
Incubating cells for a longer time (more than 24 h) was not desirable because MG
remaining inside cells can be toxic [4, 5]. In the future however, we could explore the use
of tagged mRNAs with a specific sequence that can hybridize to nucleic acid probes such
as molecular beacons, strand-displacement probes or FRET probes described in Chapters
3 and 4. This method could be useful for studying mRNA transport, localization and be
used to detect abnormal expression of certain mRNAs in cancer cells.
Our next approach towards mRNA imaging was to investigate the use of stranddisplacement activated PNA probes to image inducible nitric oxide synthase (iNOS)
mRNA in living cells. iNOS is an enzyme that catalyzes the production of NO in
eukaryotic species. Its expression is induced under inflammatory conditions or upon
environmental stimulation [6]. One of the research goals for the Program of Excellence in
Nanotechnology (PEN) grant that we were working on is to be able to image iNOS
expression in acute lung injury (ALI). We used mouse macrophage RAW 264.7 cells as a
model system for imaging iNOS mRNA expression. We first determined that there are
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about 700 copies of iNOS mRNA per cell, and upon stimulation with lipopolysaccharide
(LPS) and γ-interferon (γ-IFN), this number increases up to 100-fold to about 70,000
copies. We then designed a 23-mer antisense peptide nucleic acid probe (PNA) bearing a
fluorescein dye (FAM), whose fluorescence could be quenched by Dabcyl plus attached to
a complementary 17-mer DNA strand when hybridized to the PNA. In the presence of the
target mRNA, the shorter DNA strand was displaced by the longer complementary
section on the iNOS mRNA resulting in restoration of fluorescence to the PNA. We have
shown that the strand-displacement probe can detect target complementary DNA as well
as in vitro transcribed mRNA in solution. We have also shown that the probe can be used
to image iNOS mRNA in fixed cells, although the fluorescent intensity of the probes only
increased 3.8-fold after stimulation of the cells and not the 100-fold expected from the
RT-PCR assay. The lower than expected increase could be attributed to potential mRNA
loss during the sample preparation and high background signal from non-specifically
bound probes. We then used cSCK nanoparticles to deliver the strand-displacement
probes inside cells and were able to image the fluorescence of the probe upon
displacement by the iNOS mRNA. The matched probe showed 16.6-fold increase in
fluorescence for stimulated cells compared to the nonstimulated cells under the same
treatment while a control probe showed 4.1-fold increase in fluorescence in stimulated
cells compared to the nonstimulated cells treated with matched probe. In conclusion, we
were able to show that the strand-displacement PNA probes could be used to image the
iNOS mRNA in vitro, in situ and in living cells. However, the difference in expression
level reported by the nucleic acid probes in living cells is not as high as measured by RT-
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PCR. This may be due to a high background caused by nonspecific binding of the probes
in various cellular compartments.
Although the strand-displacement probes have been shown to be able to image
iNOS mRNA in living cells, the high relative background signal makes it difficult to
quantify the expression level.

We therefore explored another way to reduce the

background noise and increase the sensitivity that involves binary FRET probes. With
binary FRET probes, a signal can only be detected upon simultaneous hybridization of a
donor and an acceptor probe to adjacent sites on a target mRNA. We therefore
synthesized 15-mer PNA FRET pairs bearing a donor (FAM or Cy3) and an acceptor
(Cy5) fluorophore, respectively. We showed that such FRET probes could be used to
detect iNOS mRNA in vitro. We have also delivered these FRET probes into living RAW
264.7 cells with cSCK nanoparticles. The PNA probes were first annealed to partially
complementary 13-mer DNAs and mixed with the cationic cSCK nanoparticles to form
polyplexes via electrostatic interactions. The mixtures were then incubated with living
cells and the FRET images of the iNOS mRNA were obtained by confocal microscopy.
Wavelength scans were also performed to obtain the FRET spectra of the images. Cells
expressing high levels of iNOS mRNA showed an enhanced FRET signal that is 3.8
times greater than cells expressing low levels of iNOS mRNA. Probes consisting of a
FRET donor sequence and mismatched PNA-Cy5 showed almost no FRET in living cells,
further confirming that the FRET signal was due to hybridization of the probes to iNOS
mRNA, and not to formation of polyplexes with the cSCK nanoparticles.
In conclusion, this thesis has demonstrated our ability to image mRNA expression
in living cells by either transgene aptamers or peptide nucleic acid probes utilizing cSCK
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nanoparticles for intracellular delivery. There are some issues, however, that remain to be
solved before one can quantitatively image mRNA expression in vivo, which is the long
term goal of this research.
One important problem to solve is the more efficient intracellular delivery of the
nucleic acid probes to the target mRNAs in the cytoplasm. We have shown that cSCK
nanoparticles can deliver the PNA/DNA duplexes into the cells, though based on
confocal microcopy studies, the delivery is not very fast or efficient (requiring 24 h
incubation). Cells were also not homogeneously transfected, resulting in large deviations
in signal intensity between cells. We noticed that while higher doses of cSCK
nanoparticles could facilitate higher internalization of the probes, the higher doses also
caused significant cellular toxicity [7]. Current efforts under the PEN program are to
develop nanoparticles that can achieve faster delivery and that have lower toxicity, such
as acetalated dextran (AC-DEX) nanoparticles, comb-shaped nanoparticles, and cSCK
nanoparticles modified by cell targeting peptides, etc.
Another problem is the endosomal entrapment of the probes, which prevents the
probes from reaching the target mRNA in the cytoplasm. Although the quenched stranddisplacement probes and the FRET probes can minimize the signal from unbound probes,
the absolute signal intensity will depend on the efficiency by which the probes enter the
cytoplasm. Therefore, mechanisms that can improve release of the unbound probes from
the endosomes should help to increase the sensitivity of the probes. For example,
Engelman et al have reported the discovery of a pH Low Insertion Peptide (pHLIP),
which changes its structure at pH6-6.5 and inserts its C terminus through bilayer lipid
membrane [8]. Such a peptide has been used to deliver cellular impermeable molecules
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including PNAs across the membrane of cancerous cells when attached to the C-terminus
[9, 10]. In future studies, such a peptide could be conjugated to PNAs via a disulfide
bond and help translocate the probes from endosomes to the cytoplasm when the
endosomes acidify. The disulfide bond will then be cleaved in the cytoplasm and the
probes will be released.
To further improve of the optical probes for in vivo imaging, it will be necessary to
use fluorescent molecules that can emit in near infrared (NIR) range. Unlike radioactive
probes, whose signal can penetrate through deep tissues without much loss, fluorescence
in the UV-Vis range is prone to be absorbed by organs and tissues. However, tissues have
much less absorption and scattering for NIR light, making NIR dyes more suitable for in
vivo imaging [11, 12]. Dr. Achilefu’s group at Washington University School of
Medicine that is participating in the PEN program, have developed infrared dyes that can
be used for molecular imaging and in vivo studies [13, 14]. In the future, those NIR dyes
could be conjugated to the PNA probes and used for in vivo mRNA imaging.
One final improvement would be to further decrease the signal from unbound
probes. One approach to doing this would be to combine the strand-displacement probe
with the binary FRET probes developed in this thesis. Just like the dual FRET probes,
which utilize molecular beacons to quench fluorescence from unbound probes [15], two
strand-displacement probes could be employed to image mRNA in living cells (Figure
5.1). Both the donor and acceptor probes would remain quenched when there is no target
mRNA present, but in the presence of the target mRNA, both quencher strands would be
displaced thereby activating the donor and acceptor for FRET. Such dual strand-
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displacement probes would be expected to have better signal to noise ratio than the
individual strand displacement or binary FRET systems studied.

Figure 5.1: Schematic representation of dual strand-displacement FRET probes.
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